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Abstract
Background: Currently, there is no known patient reported outcome (PRO)
instrument being used in clinical practice for the home parenteral nutrition (HPN)
population. To address this gap, the Home Parenteral Nutrition-Patient Reported
Outcome Questionnaire (HPN-PROQ) was developed for use during medical
appointments or homecare visits. The purpose of this research is to provide evidence
that the items and scales of the HPN-PROQ possess content validity, a crucial step in
the process of questionnaire development.
Subjects: Qualitative sample included 32 HPN patients and quantitative sample
included 13 expert home care clinicians (physicians, dietitian, pharmacists, registered
nurses and patient advocates.)
Methods: In Phase I, cognitive interviews (CI) were conducted to evaluate HPN
patients’ understanding of the instructions, items, and response scales on a draft HPNPROQ. The draft HPN-PROQ was revised based on results of CIs. In Phase II, a
revised draft was sent to expert clinicians to complete the Content Validity Index
(CVI). Any item achieving a I-CVI kappa score ≤ 0.783 was removed. The ScaleCVI-Average (S-CVI/AVG) was calculated following a second round of CVI by a
reduced expert panel.
Results: The final HPN-PROQ contains thirty-four items with an I-CVI score ≥ 0.783.
The overall S-CVI/AVG score of the HPN-PROQ was 0.961.
Conclusion: This study provides evidence that the HPN-PROQ has acceptable
content-validity and after future validation procedures, may be appropriate as a new
tool for fostering dialogue between HPN patients and their clinicians.
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Clinical Relevancy Statement
The Home Parenteral Nutrition-Patient Reported Outcomes Questionnaire
(HPN-PROQ) is a novel tool which is designed to foster dialog between HPN patients
and providers around quality of life constructs. This study provides support for the
content validity of the HPN-PROQ.
Introduction
Background
Home parenteral nutrition (HPN) is a complex therapy involving the
intravenous infusion of nutrients and fluids to individuals who have intestinal failure
or dysfunction.1 It is estimated that 33,000 people in the United States required HPN
in 2010. 2 Most frequently, patients receiving HPN have diagnoses of short-bowel
syndrome, inflammatory bowel disease, or cancer with bowel obstruction.3,4
Quality of life (QoL) is defined by the Food and Drug Administration (FDA)
as a ‘general concept that implies an evaluation of the effect of all aspects of life on
general well-being’.5 Factors that negatively affect the overall QoL of HPN patients
are decreased physical, psychological and social function, along with increased
occurrences of depression, drug dependency, sleep disturbance, frequent urination,
fear of therapy-related complications, and inability to eat. 1,6-8 The emotional and
physical complications associated with HPN and underlying disease require extensive
lifestyle adaptation for patients and their families.9 Psychosocial factors include;
coping with a medical diagnosis, being dependent on technology, coping with the loss
of the eating experience, relying on others for care, low self-esteem, interfering with
sexual functions, and the financial burden of nutrition support.10 The emotional and

2

physical adaptations required by this technology-dependent population emphasizes the
necessity of support by a multidisciplinary medical team. This team should have the
tools necessary to effectively communicate with their HPN patients as such support is
crucial to patient-care and quality of life. One such tool is a Patient Reported Outcome
(PRO) questionnaire, which serves to collect information from patients about existing
psychosocial challenges as well as a management of their health condition.11
Winkler et al. 12 determined that HPN patients perceived their routine medical
appointments as a parenteral nutrition “tune-up”, with sessions focusing primarily on
medical or disease aspects of care. Patients self-reported that they desired a more
holistic approach to parenteral nutrition management, incorporating physical and
emotional support, in addition to medical examination and nutrition assessment.12 If
used in clinical practice, PRO instruments could provide support to patients because
feedback is provided to the clinicians with the goal of helping them manage patient
care.11 Such instruments can be invaluable in facilitating patient-clinician
communication around QoL.11 Although the use of PRO instruments in clinical
practice can improve the interactions between patients and their clinicians, the Sustain
Registry, a national patient registry for nutrition support, reports that <2% of enrolled
HPN patients have had QoL constructs measured or assessed.4,11
There is one validated HPN-specific QoL instrument to assess the HPN
population, the Home Parenteral Nutrition Quality of Life Questionnaire.13 This
instrument has been used to score and assess changes in QoL among HPN patients
receiving pharmacological interventions.13,14,15 However, the HPN-PROQ was
developed with a different purpose in mind than that of the HPN-QoL. Rather than

3

producing an overall score of the patient’s QoL, the HPN-PROQ is an instrument that
may enable a HPN patient to easily complete a PRO questionnaire in a clinical setting
and prioritize important medical and non-medical issues for discussion with clinicians.
The purpose of this study is to assess the content validity of the HPN-PROQ.
Once the instrument has undergone this rigorous content validation process and future
studies conduct psychometric testing, and clinical validation, the HPN-PROQ could be
applicable for use in the clinical setting with adult HPN patients residing in the United
States.
HPN-PROQ Development
The draft HPN-PROQ was developed after a comprehensive literature review,
expert clinician feedback, and qualitative research by Winkler et al.1 , which explored
the lived experiences of HPN dependent adults. Qualitative research revealed that GI
symptoms (with or without an ostomy), eating and mealtimes, energy level and ability
to do activities of daily living, sleep, psychosocial function and coping, and the
complexity of technology and training for HPN, all influenced self-perceived QoL of
HPN patients.1
The draft HPN-PROQ included two sections with a total of 54 items. Section
One asked patients to report how often they experience specific situations during the
previous two-week period. A four-point Likert response-scale was chosen for this
section: “never”, “2-3 days per week”, “more than half of days”, and “nearly every
day”. Constructs included: eating and mealtimes, psychosocial functioning and
coping, HPN management, energy level and ability to do activities of daily living,
sleep, and GI symptoms (36 items total). Items relating to GI symptoms were
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differentiated by anatomy (ostomy or bowel in continuity). Section Two included 18
true/false items. A four-point Likert response scale was chosen for this section:
“mostly false”, “somewhat false”, “somewhat true”, and “mostly true”. Constructs
included: QoL, living with HPN, and HPN equipment-related knowledge.
A crucial step in the development of questionnaires is to provide evidence that
the items and scales possess content validity.5 When testing the content of a newly
developed PRO, there are two primary components of importance.16,17 First, what is
the intent of the question: what do respondents believe the question is asking? Second
is the meaning of specific terms in the instrument: what do specific words and phrases
in the instructions, items, and/or response options mean to respondents? Is that
meaning consistent with the intent of the researchers?18 Because PRO instruments
assess concepts most relevant and important to a patient, content validity must be
established as it is the extent to which an instrument assesses the concepts it proposes
to assess.18
Figure 1 illustrates the process of content validation and where it falls in instrument
development and validation. This figure has been adopted from Schildmann et. al.19
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**Steps denoted in white shaded boxes were completed in this study.
Figure 1: Instrument Validation Process Flow
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Methods
This study assessed the content validity of the HPN-PROQ using a two phase
mixed-method study design; qualitative methods and quantitative methods via the
administration of the Content Validity Index (CVI).20 The purpose was to modify this
draft based on cognitive interview (CIs) feedback from HPN patients (Phase I)
followed by expert review with home care clinicians who completed the CVI (Phase
II). (See Table 1) This study protocol was reviewed and approved by the University of
Rhode Island’s Institutional Review Board (IRB) prior to the start of recruitment.
Table 1: Content Validation Methods Process Flow
*Start: draft HPN-PROQ
Method
Sample

Phase

Result

Qualitative
I

Cognitive Interview &
analysis of feedback to drive
decisions for revision to
draft.

HPN Patients

Modified draft HPNPROQ

HPN Expert
Clinicians

Content Valid HPNPROQ

Quantitative
Content Validity Index to
determine “excellent” item
and scale relevance of
modified draft.

II

Sampling
HPN patients
Similar to Chopy et al.21, the Oley Foundation, a national, independent, nonprofit 501(c)(3) organization serving HPN patients through education, advocacy, and
networking, approved the study protocol and, agreed to post and distribute
announcements calling for study volunteers. (Recruitment materials can be found in
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Appendix E). Eligibility requirements for HPN patients included being 18+ years of
age, receiving HPN, speaking English, living in the U.S., having an active email
address, and ability to access a computer while simultaneously being on the telephone.
Exclusion criteria included being pregnant and those receiving enteral nutrition. Study
patients self-selected to participate by contacting the research email address. Each was
sent the eligibility screener including seven questions to verify eligibility: “Do you
live in the US?”, “What is your age in years?”, “Are you pregnant?”, “Are you
receiving home TPN?”, “Do you speak English?”, “Do you have computer access?”,
“Can you talk on the telephone and read on the computer at the same time?”. A target
number of cognitive interviews (n=30) was chosen by the research team prior to the
start of Phase I. Demographic information included medical diagnosis, length of time
dependent on HPN, number of infusions per week, number of infusion hours per day,
age, sex, race, number of people in household, and highest level of education.
Microsoft Office Excel (2017) was used for descriptive statistical analysis and results
are reported as mean and frequency.
HPN Experts
For Phase II, a convenience sample of expert HPN clinicians identified through
publication (recognized contributions to the literature on the topic of HPN), leadership
in the American Society for Parenteral and Enteral Nutrition home care section, and
the Oley Foundation were asked to participate. The expert panel included physicians,
registered dietitians, pharmacists, registered nurses, and home-care advocates. The
goal was to recruit 12 experts as this is an acceptable sample size for completion of the
CVI and is comparable to other studies.20,22-24 A reduced panel utilized a second round
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of the S-CVI/AVG after analysis of full CVI panel results. This sample was also
stratified by profession in order include input from commonly included members of a
medical team who serve the HPN population.
Data Collection Phase I: Cognitive Interviews
All interviews were audio-recorded on a Sony ICD-PX333 digital voice
recorder and notes were taken during interviews to keep an audit trail and enhance the
researchers’ understanding of the recorded conversations. During semi-structured
interviews, a verbal probing cognitive interviewing technique was employed. 25 The
interviewer used the following probes: verbal probes (“what does the term xyz mean to
you”); paraphrasing (“please repeat the question I just read to you in your own
words.”); recall probe (“how do you remember how often you experienced xyz in the
past 2 weeks?”); and general probes (“would this be easy or hard to answer? I noticed
that you hesitated - tell me what you were thinking”).26 Patient responses to probes
served to guide the interviewer to probe more efficiently in future interviews and to
collect more streamlined data. After all interviews, patients were asked to share their
“overall impression” of the HPN-PROQ (i.e. if they felt the instrument would be
useful in starting a conversation with any of their health-care clinicians.)
Recordings from each interview were transcribed verbatim, de-identified, and
saved as Microsoft Word (2017) documents. The collaborative research team (CRT)
met frequently throughout the qualitative data collection process to discuss potential
revisions to the draft HPN-PROQ. In cognitive interviewing, data collection and
analysis is an iterative, concurrent, and interrelated process. Patterns and themes were
identified in an ongoing manner throughout Phase I.25
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A pilot interview was conducted to test the interview template/script and to
establish an estimation of the time required to complete the interview. This interview
was not recorded and data from this pilot interview are not included in results.
Because of the length of the pilot interview (approximately 97 minutes), round-one
CI’s were split into two sets. See Figure 2. Round-one interviews were conducted to
evaluate the overall relevance, comprehensiveness and suitability of items,
instructions, and response scales on the draft HPN-PROQ with the purpose of
subsequently modifying the questionnaire based on interview feedback. Specifically,
set one interviews (n=10) evaluated items Section One items 1-20 and set two
interviews (n=10) evaluated items Section One items 21-36, and Section Two, items 118. All round-one interviews tested the 4-point Likert response-scales included in the
draft HPN-PROQ.

Round 1: Set 1
CI's 1-10

• Test Items
Section One,
1-20,
instructions,
response scale

Round 1: Set 2
CI's 11-20

• Test Items Section One 21-36, Section
Two items 1-18, instructions, response
scale
• Test all
modified items
and response
scales from
Round 1

Round 2
CI's 21-32

Figure 2: Cognitive Interview Process Flow
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Each patient received the draft HPN-PROQ via email 5-10 minutes prior to the
interview call. Patients were not asked to complete the draft HPN-PROQ. During
interviews, the researcher focused on the interpretation of the items rather than
considering how the patient would respond. The method of returning analyzed data to
a participant, known as member checking, is often used to validate data collected in
one interview by checking with another informant before subsequent interviews are
conducted.27, 28,29 After first round interviews and prior to starting round two
interviews, a second interview (member check) was conducted with all round one
patients (n=20) to review some projected modifications to the draft HPN-PROQ.
These patients were contacted via email and asked to participate in a “member check”
interview to discuss proposed modifications to the questionnaire.
Following round one interviews and member checking, thematic analysis of
interview data was used to inform all necessary revisions to the draft HPN-PROQ. To
ensure a robust set of findings, the revisions to the draft HPN-PROQ were tested in
round-two interviews. Round two patients (n=12) were sent the modified draft HPNPROQ and interviews were conducted to assess the clarity, relevance, and
interpretation of the revised items and response scales. Patient feedback was again
analyzed, and the CRT assessed the need for further revisions. Potential revisions to be
included in the final draft were tested via member checking and in three final
interviews. (i.e. interviews 29-32)
At the completion of Phase I, the CRT met to finalize all revisions before
proceeding to Phase II. Qualitative data are presented and reported as representative
quotes from HPN patients.
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Data Analysis Phase I: Cognitive Interviews
Interview data were summarized and evaluated by the CRT and ultimately
informed revisions to the draft HPN-PROQ. All decisions to change or modify any
aspect of the questionnaire during Phase I were based solely on interview data and
decisions made by the CRT based on these data.
Transcript contents were organized on an item-by-item basis using Microsoft
Excel. By combining itemized patient feedback pertaining to each item, a crossinterview data matrix table was developed to aggregate feedback across interviews and
seek patterns that identify key findings. Thematic analysis was used to sort and
condense these data into themes, support decisions for revision to the questionnaire,
and identify non-problematic items. A “theme” serves to categorize data and
represents a level of patterned responses or meanings within the data set. 30 Thematic
analysis offers a “theoretically-flexible” approach to analyzing qualitative data and
serves to organize a rich and detailed, yet complex account of data into meaningful
results.30 Throughout this process, members of the CRT met frequently to discuss
interview feedback and decide upon potential revisions to the draft HPN-PROQ.
Careful consideration was given to vague or ineffective instructions, confusing
questions and response options, variable interpretation of terms, general signs of
misinterpretation by the patient and potentially reactive or offensive items.
Data Collection Phase II: Content Validity Index
Following the completion of Phase I, a CVI Worksheet representing the
modified draft HPN-PROQ (see Appendix G) was administered via email to 13 HPN
expert clinicians who agreed to participate in the study. Each participant returned the
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CVI worksheet to the research email address and data were entered in Microsoft Excel
(2017) software for analysis. After determining any necessary deletion of items based
on I-CVI criteria of ≥ 0.783, five experts (one physician, pharmacist, registered
dietitian, registered nurse, and home care advocate) were chosen based on order of
completion of round one CVI worksheets. (i.e. the first participant in each profession
to complete the worksheet and return it to the research email was selected). These
experts were sent a modified CVI Worksheet which excluded items not meeting the
criteria for retention. Four experts returned the worksheet and data were entered in
Microsoft Excel (2017) software for analysis. One expert clinician (registered nurse)
did not respond to the research email with round 2 responses to the CVI.
Data Analysis Phase II: Content Validity Index
The I-CVI was calculated by having the experts rate the relevance of each item
to the HPN population (1=not relevant, 2=somewhat relevant, 3=quite relevant,
4=highly relevant). The I-CVI of each item is defined as the number of experts
offering a rating of “3” or “4” on each item, divided by the total number of experts and
expresses the proportion of agreement by all experts on the relevancy of each item, as
number between zero and one.22 For example, an item rated as ‘‘quite’’ or ‘‘highly’’
relevant by four out of five expert clinicians would have an I-CVI of 0.80.
The I-CVI was then adjusted for chance agreements using a multi-rater kappa
statistic proposed by Wynd et al.31 The kappa statistic represents the proportion of
agreement remaining after chance agreement is removed.31 The multi-rater kappa
statistic is described as follows.
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Where Pc is the probability of chance agreement, n is the number of experts, and A is
the number of approving with “good relevance”.31 K was calculated using the I-CVI
and probability of chance agreement as follows:

k∗ =

ICVI − Pc
1 − Pc

Each item on the scale was rated as “fair”, “good”, or “excellent” based on the
following rating criteria: fair, K = 0.40-0.59; good, K = 0.60-0.74; excellent, K > 0.74.
In the content validation of questionnaires, any item receiving a I-CVI kappa statistic
≥ 0.783 is considered to have high relevance and should be retained, and any item
receiving a kappa < 0.783 should be removed from the questionnaire.20
The Scale-CVI/AVG (S-CVI/AVG) was calculated using Microsoft Excel
(2017) software. The S-CVI/AVG is the average I-CVI scores across all items.31
SCVI/AVG =

∑ICVI
n

Where n= the number of experts, a S-CVI/AVG over ≥ 0.83 is deemed acceptable in
the content validation assessment of a newly developed instrument.20 If deletions
occur as the result of the I-CVI, the S-CVI/AVG can be repeated with a reduced panel
to demonstrate differences in these scores after modification to the questionnaire.31
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Table 2: Demographic Characteristics of HPN Patients Participating in Cognitive
Interviews (N=32)
Female sex, %

71%

White race, %

98%

Marital Status, % married

61%

Caregiver present, %

35%

Highest Level of Education (n)

Doctorate n=2
Masters n=6
Bachelors n=7
Associates=2
High School Diploma n=15

Medical diagnosis relating to need for HPN
(n)

Short Bowel Syndrome n= 22
Gastroparesis n=3
Pseudo Obstruction n=4
Intestinal malformation n=1
Severe Food Allergy n=1
Mitochondrial Disease n=1

Number of people living in household, mean
+/- SD (range)

2.4 +/-1.5 (1-7 people)

Age (years), mean +/- SD (range)

52 +/-15 (22-73 years)

Years on HPN, mean +/- SD

12.0 +/- 10.5 (1.2-34 years)

HPN infusions per week, mean +/- SD

6.5 +/- 1.1

HPN infusion hours, mean +/- SD

12.0 +/- 3.7

*HPN=Home Parenteral Nutrition

15

Results
Phase I: Cognitive Interviews
Fifty-five adult HPN patients contacted the research email address indicating
their interest in participating. Forty-three HPN patients replied to the screener email
and 38 were determined eligible. Thirty-two patients comprised the study sample.
Participant’s mean age was 52 years (+/- 15 years), 71% female (n=23), and 98%
Caucasian (n=31) with a diagnosis of either short bowel syndrome (n=22),
gastroparesis (n=3), pseudo obstruction (n=4), intestinal malformation (n=1) severe
food allergy (n=1), or mitochondrial disease (n=1). All participants possessed at least a
high-school diploma, and 46% (n=15) had achieved a bachelor’s degree or beyond
(See Table 2).
The mean length of time for round one interviews was 51 (± 9) minutes and for
round two interviews was 37 (± 10) minutes. Four themes were identified during
qualitative data analysis.32 (see Appendix F). Based on this analysis, problematic items
or response scales were revised or deleted.
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Concerns with tone: Patients voiced concerns about the phrases “normal lifestyle”,
“controls my life”, and “limits my freedom”. These phrases elicited unfavorable
comments, indicating the items’ tone may be overly negative. For example, the item
“I am able to live what I consider a normal lifestyle” elicited the following comment
from one patient who felt the item would be difficult to answer; “…this one is a little
harder to answer… because I think normal is hard to define for everybody…that
would need some parameters”. Another patient provided similar feedback; “…that’s
kind of a hard one, because people have different lifestyles.” One bluntly stated; “I
don’t live a normal lifestyle.”
Issues with ambiguity and meaning: Across interviews, some items and phrases were
inconsistently interpreted. For example, several patients requested additional
clarification around the meaning of the phrase “many times”. Several patients
requested that the interviewer quantify what was meant by “many times”. One patient
felt the question would be difficult to answer, “I would wonder about what you mean
with ‘many’ times.” Clarification was needed on several occasions around the concept
of being “satisfied or “coping”. For example, “I am satisfied with the amount of sleep
I get” was difficult for some patients to conceptualize; “… someone can be satisfied
with no sleep so it’s very individual”.
Concerns with use of jargon or word choice: Patients voiced concern with the
terminology used in some items. Patient feedback assisted in the refinement of these
items to reflect more general terminology, or more commonly used terms and phrases
in the HPN population. For example, the term “ostomy appliance”; one patient
explained that this term is rarely used in their daily language, “…I have a big issue
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with this. I tell my nurses when they ask me about changing my ostomy appliance that
I don’t change it more than once a day but I empty it frequently… changing and
emptying is two different things so I would change that.”. Another patient suggested
the word “change” be revised to “empty”, “…change is not appropriate in here...you
don’t change it, you empty the bag.”. When these changes were tested in subsequent
interviews, patients agreed with this feedback, “I agree, I think I tend to call it a bag.”

Table 3: Utility of the HPN-PROQ Representative Quotations
“I think these questions are phenomenal. I think they nail it…doctors don’t ask
that (these questions) ...but this feels so human and full empathy, I really
appreciate this kind of questions”.
“Yes, I think it (the HPN-PROQ) would benefit and give them (clinicians) an
idea on how you’re doing on TPN, that broad questions show them how it’s
affecting everyday of your life and not just how you’re doing right now.”
“I do (feel the HPN-PROQ would be useful) provided a doctor actually takes
the time to kind of divulge in these kinds of things. Most of the time they’re
like “ok here’s your action and what you have to do” and the home nurse will
explain it all to you. There’s not much (conversation) beyond that, the
treatment plan…”
“A lot of times the patients want to talk about how they feel, but the physicians
don’t.”
“They know the medical “in’s and out’s” in terms of intestine and bowel
(issues) but they are clueless to what the TPN patient goes through
emotionally and physically”.
“Yes it (the HPN-PROQ) would spark a conversation…if you said you have a
concern about your diet or diarrhea and they can offer you a dietitian.”
“I think it’s excellent it gives somebody topics to focus on when you’re at the
doctor and you have many questions to ask and they you go home and you
remember that you forgot to ask some question… so I think it’s a great
conversation starter to have them (patients) fill it (the HPN-PROQ) out and
discuss it during the visit.”
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HPN-PROQ Utility : Overall, patients provided very positive feedback regarding the
use of the HPN-PROQ and were supportive of the development of the instrument.
Patients described the draft HPN-PROQ as “useful”, and the items as “beneficial”,
“human”, and “empathetic”. Representative quotations supporting this theme can be
found in Table 3.
Revision to Response Scales and Instructions: Across round one interviews, patients’
interpretation of middle response options of the four-point Likert Scale varied widely
across interviews. For example, patients described the response option “2-3 days per
week” as “…three to four days per week.”; “…maybe six times.”; “…I would say four
days per week.”. The response option “more than half of days” was described as
“...four days per week”, “more than seven days.”; “anywhere between eight to 13
days”. These inconsistencies showed that revision to the response scale was necessary.
The response-scales were changed to Visual Analog Scales (VAS) with the stems
“Not at all” and “Every day” for Section One, and “Definitely false” and “Definitely
true” for Section Two. The decision to use a VAS was based on review of relevant
literature that indicated a VAS would be a suitable response scale for the intended
utility of the HPN-PROQ.33 Revisions to the response scale were tested with all
patients from round one interviews via member checking. One hundred percent of
round one interviewees (n=20) participated in the member check, and the majority
(n=16) agreed with the need to revise the response option and preferred the VAS to
the Likert Scales. Patients described the VAS as “better”, “less time consuming”, “a
great visual” and “more accurate”. The VAS was included and tested in round two
interviews. The instructional set for Section One was also revised; “please indicate
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how often you experienced any of the following situations in the past two weeks” to
“please estimate how often you experienced any of the following situations in the past
two weeks”. This change was also tested via member checking and was found to be
appropriate.
Additional Revisions
In addition to the revisions driven by participant feedback and qualitative data
analysis, structural changes to the draft HPN-PROQ were made by the CRT. Three
items in Section 1 were moved to Section 2 (true/false). “I feel supported by my family
and friends”, “I eat and enjoy the foods I want to eat”, “I am confident with my ability
to perform TPN procedures on my own.”. These items were tested as true/false items
in interviews 29-32. Participants agreed with this revision and felt the questions were
better suited for section two of the questionnaire.
Other results of interest in this study are the patient’s interpretation of the item
relative to the definition of QoL. Winkler’s definition of QoL for the HPN population,
defined as “doing what I want to do when I want to do it”.1 Participants in our study
agreed strongly with this QoL definition “doing what I want to do when I want to do
it”. This item was repeated verbatim by many participants and feedback supported
this QoL definition in the HPN population. One patient stated “I think it’s very
clear...it pretty much sums it up. I like that statement”. Another agreed by saying, “I
think good quality of life means being able to do what I want do”.
Summary
Many items (n=29, 54%) were described as “understandable”, were deemed
acceptable, and viewed as comprehensible, acceptable, “clear” and “easy to answer”.
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These items were interpreted as intended by the researchers and participants
consistently rephrased them verbatim. These items did not require revision and were
retained, whereas items or response scales viewed by participants as being problematic
were revised or deleted from the instrument (deleted; n=11, 20%, revised; n=14, 25%).
The modified draft HPN-PROQ tested in Phase II contained 43 items and included
two sections: Section One (24 items) with a VAS response scale (stems “Not at all”;
“Every day”). Section Two (18 items) with a VAS response scale (stems “Definitely
false”; “Definitely true”).
Phase II: Quantitative CVI
Thirty-three home care clinicians were invited to participate in the expert panel
CVI. Thirteen expert reviewers, stratified by profession (physicians n=2, pharmacists
n=3, registered dietitians n=3, registered nurses n=2, home care advocates n=3),
agreed to complete the CVI with the modified draft HPN-PROQ. The first participant
from each profession to complete the I-CVI from round one was selected for round
two of the S-CVI/AVG. This sample included one physician, one registered dietitian,
one pharmacist, and one homecare advocate.
Individual, adjusted, multi-rater kappa scores were examined for each of the
items on the modified draft HPN-PROQ following cognitive interviews. Thirty-four
items scored as “excellent”, with an I-CVI score ≥ 0.783, and nine items were deleted
based on a I-CVI score < 0.783, indicating low relevance to the HPN population .34
See Table 4 for an item by item analysis of the I-CVI.
The S-CVI /AVG score was calculated in two rounds: prior to modification
based on I-CVI analysis and again after the removal of the nine items not meeting
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criteria for relevance. The S-CVI/AVG score improved from 0.91 in round-one to 0.96
in round two. The final S-CVI/AVG score was > 0.80, which is considered acceptable
for the content validation of newly developed PRO questionnaires.20
Discussion
Patient reported outcome questionnaires serve to increase awareness on both
the patients’ and clinicians’ behalf, as they facilitate discussion around QoL
constructs, treatment plans and goals, and patient knowledge of caring for their
medical condition and/or treatment.35 There are many factors affecting the QoL of
HPN patients, signifying the need for clinicians to have the tools necessary to support
their patients not only medically, but also psychosocially. Researchers have concluded
that assessment of QoL in this population should be facilitated using a therapy-specific
instrument.1, 10, 36 Currently, only one validated QoL instrument exists to clinically
evaluate the HPN patient, however, use of this instrument has only been published in
research studies thus far.14, 15 The HPN-PROQ was developed with patient-clinician
communication in mind. Once validation procedures such as content validity, clinical
relevance testing, and psychometric validation, are completed, the HPN-PROQ could
be used to foster communication between the patient and clinician around issues
impacting their QoL. The purpose of this study was to demonstrate the content validity
of the newly developed HPN-PROQ in a sample of adult HPN patients in the U.S.
Presently, the HPN-PROQ may be more suitable for use in clinical practice in
the U.S. than the only other instrument, the Home Parenteral Nutrition Quality of Life
(HPN-QOL©) given the in-depth involvement of adult U.S. HPN patients and
clinicians in both the generation of items and in the content validation of the
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questionnaire. Additionally, the HPN-QOL© has only been validated in European
cultures, and therefore may not be applicable for use in the United States.37 Another
critical difference between the HPN-QOL© and the HPN-PROQ is that the HPNQOL© is designed to be a scored instrument, i.e. generates a number that can be
compared over time and/or with other populations (normal/well or disease-specific).
The HPN-PROQ does not produce a score, but instead allows a subjective approach to
the evaluation of issues that may impact QoL. Use of the HPN-PROQ could help
patients prioritize specific areas that they may wish to discuss with their clinician. It
also allows patients the opportunity to explain their concerns to their clinician in more
detail and discuss why they are feeling the way they are feeling.
The VAS response scale makes this questionnaire a more “user-friendly”
instrument for both patients and clinicians than a Likert Scale. 33 Use of VAS in the
clinical setting with self-administered questionnaires is common.38 Visual Analog
Scales are frequently used to evaluate pain, mood, and patient satisfaction, are
advantageous in that they are less vulnerable to bias from confounding factors linked
to Likert scales (i.e. ambiguity of response descriptors/options), and require less time
to complete.33 Our sample of HPN patients expressed a preference for the VAS and
considered the VAS superior to the Likert Scale. They noted that the VAS would be
“easier to use”, a “good visual”, and “possibly more accurate”. Because the purpose of
the HPN-PROQ is to facilitate discussion rather than produce a final score, the VAS
may provide a better “snap shot” than what could be obtained with a Likert scale. The
HPN-PROQ de-emphasizes the significance of overall/total scores and may turn
attention to factors influencing QoL and lifestyle adaptation with HPN. This could
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allow for clinicians to pay attention to individual response patterns to decide what type
of care is needed. Because patients may be embarrassed or hesitant to initiate
conversations with their clinicians around psychosocial issues, having the HPN-PROQ
may facilitate discussions between clinicians and their patients.
Validation of newly developed instruments is a rigorous process which
includes the establishment of content validity.18 The importance of content validity in
developing PRO instruments is emphasized by both the US Food and Drug
Administration and the European Medicines Agency 5, 39. The US Food and Drug
Administration also highlights the importance of including substantial patient input in
PRO development.5 We have included a target population of HPN patients and an
iterative qualitative research process to confirm content validity.5 Although addressing
all concerns and suggestions made by every participant was not possible,
demonstration that the new PRO instrument is understandable to potential respondents
is essential in evaluation of content validity.18
Cognitive interviewing is commonly employed to improve the content validity
of newly developed PRO instruments because they should utilize common terms
understood by the target population. In this study, results from cognitive interviews
demonstrated that many items were understood by HPN patients in the original form
written, were interpreted by HPN patients as intended by the researchers, and were not
found to be difficult to recall or challenging to answer. HPN patients provided several
suggestions in relation to word-choice and issues with jargon. Cognitive interviewing
is an evidence-based technique to assist researchers in providing content validityevidence by assessing the participants interpretation of items during interviews.40 It is
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important to recognize that data collected from cognitive interviews are qualitative in
nature and are mainly used to assess and improve questionnaire items before the
questionnaire is implemented.41 Cognitive interviewing requires a level of
understanding of patient issues alongside the ability to listen, interpret, and accurately
report patient comments; none of which are reflected in quantitative research.42
Although not frequently reported in the same detailed or robust manner as in this
study, many content validation studies use cognitive interviewing in the target
population as a means to improve validity.13, 14, 42, 43, 44, 46
We identified item-specific issues with lack of clarity regarding word choice,
comprehension, and ambiguity and uncovered potentially problematic items and terms
not previously identified in HPN-QOL© validation studies. For example, patients
suggested using “central line” to replace “catheter” and “emptying an ostomy bag”
instead of “changing the appliance”. This study builds upon the validation of the HPNQOL© by informing researchers of the value of patient input in questionnaire
development and validation.
This study possessed many strengths, one being the combination of qualitative
and quantitative methodology. This study possesses rigor in qualitative research which
was accomplished by having a sound scientific methodology and protocol, which
included semi-structured interview scripts, appropriate analysis of the data, and
documentation of findings.42 The use of quantitative data in the absence of thorough
collection of knowledge, frameworks, and qualitative considerations can potentially
produce a clinically ineffective instrument. It also should be recognized that the use of
qualitative data alone to substantiate an instrument may be rhetorically convincing, but
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scientifically incomplete.18 Keeping in mind the broader patient-centered philosophy,
collaboration with the target population in early development and validation stages can
ensure effective handling of sensitive content, and possibly prevent attrition that could
result from invasive or offensive content.45
Cognitive interview projects are normally small in scope and may involve just
10 participants. 13, 14, 42, 43, 44, 45 Characteristics of the sample should reflect as closely as
possible the patient population to be included in future studies that will incorporate the
PRO.48 This study conducted two rounds of interviews to provide ample opportunity
for problematic items to emerge.32 The target sample for this study was adult patients
receiving HPN. The demographics, diagnoses, length of time receiving HPN, and
length of infusion schedule compares favorably to similar studies. 4,21 Demographic
data from in our sample is comparable to the Sustain Registry in that short bowel
syndrome was the primary indication for HPN adults (28.7%) and the Sustain cohort
was predominantly female (59%) and Caucasian (75%).4 Our sample was also
homogenous (98 % Caucasian, 71% female) and our sample size of 32 was
comparable, if not stronger than, other published sample size criteria for content
validation via qualitative methods.18 It was determined during review of transcripts
and analysis that data saturation was achieved in our sample (n=32). Data saturation is
the point in data collection and analysis when new feedback no longer contributes
significant information. 32
Five experts or more are required to have a valid sample for CVI.20 We
exceeded this target as well as stratified our sample by profession given the multidisciplinary team often involved in the care of HPN patients. Our sample included
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clinicians with experience managing HPN, two physicians, three pharmacists, three
registered dietitians, two registered nurses, and three home care advocates. HPN
expert home care clinicians rated most items as having “excellent” relevance, leading
to a highly acceptable S-CVI/AVG score. The I-CVI of the items on the HPN-PROQ
were analyzed using conservative criteria for retention; only the items accomplishing a
kappa I-CVI rating ≥ 0.783 were retained resulting in the deletion of nine items. The
final overall S-CVI/AVG was 0.96. This as an acceptable score and is comparable to
the results of other content validation studies.23, 24, 34, 44
The results and methodology of this study are consistent with similar content
validation studies using the CVI to determine content validity of a newly developed
questionnaire. The Osteoporosis Risk Assessment Tool (ORAT), eight experts were
selected from nationally known clinicians and researchers holding well-respected
reputations in the area of osteoporosis risk prevention and treatment.48 This study used
an acceptable level of relevance score of 0.58 to determine item relevance and criteria
for the deletion or retention of items on a draft questionnaire.48 In the development and
content validation of an instrument for measuring patient-centered communication,
fourteen designated experts completed the CVI using a modified kappa statistic to
quantify item relevance.23 Compared to our study, researchers in this study used a
more liberal CVI criteria (>0.70) to determine item retention; resulting in the removal
of 4 items from the prototype questionnaire. Similar to this study and by using a
slightly smaller sample (n=9), Larsson et al.24 used the CVI in the validation of a
muscle endurance questionnaire with an I-CVI criteria of (>0.78) to indicate
“excellent” relevance; resulting in the deletion of fourteen items.
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Five items in Section One of the modified HPN-PROQ were slightly lower
than criterion for retention based on the I-CVI. (i.e. they scored at 0.77 vs. 0.78).
While this reduces the number of items on the questionnaire and decreases participant
burden, elimination of these items may leave out some important constructs of HPNrelated quality of life. The CRT thought that these items’ topics are sufficiently
covered by other items included in the questionnaire that were not eliminated. For
example, I am able to walk up and down the stairs without difficulty” was eliminated
but this topic could be sufficiently assessed by “I am able to walk without difficulty”.
Three items pertaining to patients’ experiences with eating (i.e. bloating, pain, cramps
as the result of consuming foods) were deleted from the questionnaire due to I-CVI
scores. This does not mean to imply that this construct is irrelevant to the HPN patient
population, as numerous studies have demonstrated its importance.1,3,6,7 It should be
noted that these items represent aspects of eating that are physical in nature, rather
than psychosocial in nature, and two remaining times assessed eating-related issues,
justifying the removal of these items from this QoL instrument. However, in future
clinical validation studies, clinicians and patients may find that these physical foodrelated issues are relevant and therefore should be included in the HPN-PROQ. By
design, the CRT felt that the general nature of some items retained on the
questionnaire could be useful to cue the physician to ask the patient to describe more
specifically what they are struggling with. This fosters the one main purpose of the
HPN-PROQ, which is to drive these conversations between the patient and the
clinician.
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PRO instruments can enhance patient–clinician communication and inform
plans of care to better target interventions that will improve patient outcomes. 50, 51
Evidence from randomized controlled trials suggests that the use of PROs in clinical
practice is valuable in improving the discussion and detection of QoL constructs, but
has less of an impact on how clinicians manage patient problems or on subsequent
patient outcomes.35 Many of the reasons for this may lie in the ways in which PROs fit
(or do not fit) into the routine ways in which patients and clinicians communicate with
each other, how clinicians make decisions, and how healthcare is organized.
Greenhalgh et al.35 suggests future research should seek to identify ways in which
PROs can be better incorporated into the routine care of patients by combining
qualitative and quantitative methods. Regardless, use of PRO instruments can provide
several advantages: as a means to alert the clinician to the patient’s concerns about
their QoL, to clarify via discussion the patient’s priorities for care, and to facilitate
conversation between patients and clinicians about these issues.50 This is especially
important as patients and physicians do not always agree on which outcomes of care
are most important.51 For example, patients with multiple sclerosis and possibly those
with other chronic diseases are less concerned than their clinicians about
physical disability in their illness and are more concerned with issues impacting their
QoL.52 Studies have also shown that provision of PRO feedback to clinicians results in
an increase use of health services and referrals, more timely reporting and
management of symptoms, less patient anxiety, fewer preventable emergency room
and office visits or calls, greater patient adherence to advice, greater satisfaction with
care, more effective self-management, and more efficient use of resources. 49, 53, 54
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The HPN-PROQ illustrates acceptable quantitative and qualitative indices for
content validity, as determined by HPN patients and expert home care clinicians.20
Future quantitative validation of the revised scale and items should be considered
alongside a large sample of HPN patients to provide quantitative support for the
conceptual framework of the HPN-PROQ, specifically, it will be important to compare
results from the HPN-PROQ to the HPN-QOL©. Clinical validation should also be
conducted to assess the impact of the HPN-PROQ on treatment decision making.
Specifically, future studies should include observations of patient-clinician interaction
while using the HPN-PROQ with an assessment of patient and clinician satisfaction
and communication. Lastly, all PRO instruments should be translated into different
languages, including forward and backward translation methods.18 Many healthcare
settings serve diverse populations with diverse language preference. Translation of the
HPN-PROQ into other languages would prevent a relative or friend having to translate
the questionnaire to the patient, potentially interfering with validity.
Limitations
There are some limitations in content validity studies that should be noted.
Expert feedback is subjective, and may introduce biases to the study, that may exist
among the experts. Additionally, there was a demographic limitation in the CI sample
which had a high rate of Caucasian females (71%). However, there is no reason to
suspect that this would impact our data in a way that would impair the clarity,
relevance, and acceptability of the revised components of the HPN-PROQ. Selection
bias is likely as participants were self-selected, interested, and willing to participate.
Lastly, this study was conducted with adult HPN patients only and therefore, results
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are not generalizable to pediatric patients or their parents or caregivers. [most parents
or caregivers act as proxy for young children who cannot complete QoL or other
questionnaires.] Future studies should incorporate these populations.
Conclusion
To the best of our knowledge, this study adheres to standard procedures in
content validation and our data provides evidence that the final version of the HPNPROQ is a content valid questionnaire with relevant, clear, and refined items and
response scales. We are confident that the HPN-PROQ meets the standards set forth
by the FDA in terms of content validity, item readability, and understanding for the
development of a PRO instrument. Cognitive interviewing, member checking, and
calculation of the CVI were utilized to demonstrate the content validity of the HPNPROQ. The methodology used in this study (i.e. interview scripts, iterative analysis,
actions taken to delete or modify an item in response to the cognitive interviews, and
member checking) are appropriate to assess content validity.18 These methods help
provide a valid set of items which will in-turn increase the likelihood of reliable
responses from HPN patients.18 Overall, the majority of items included in the original
HPN-PROQ were understood by HPN patients and interpreted as intended by the
researchers. The questions were described as “clear” and “easy to answer” and
represented important areas in the lives of HPN patients.1
Although the primary intent of the cognitive interviews was to evaluate if HPN
patients in our sample understood the items and could offer congruent interpretations,
we also further identified the patient need for a HPN therapy specific instrument to
support the HPN population in clinical practice. Patients frequently expressed their
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gratitude for the work of project and were eager to participate; repeatedly commenting
on the relevance of the issues raised in the HPN-PROQ and how effectively
communicating with their clinicians about these issues is meaningful to them. This
study found that patients perceived the need for an instrument such as the HPN-PROQ
which could be used to facilitate communication among HPN patients and their
clinicians to assist in the improvement of patient-care.
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Table 4: Content Validity Index Data Quantitative Analysis
Number of Experts
giving a rating of a
Item
“3” or “4”
Section 1

k

1.

I felt like my health limited the
things I want to do in my life.

13

1.00

2.

Being on TPN was difficult to
cope with emotionally.

13

1.00

3.

My daily activities were limited
by my TPN infusion schedule.

11

0.85

4. *

Carrying my TPN solution limited
what I could do.

10

0.77

5. *

I felt physically strong.

10

0.77

6.

I was able to participate in the
activities I enjoy.

12

0.92

7.

I was able to walk without
difficulty.

11

0.85

8. *

I was able to climb up and down
stairs without difficulty.

9

0.69

9.

I was able to rise from a chair or
bed without difficulty.

12

0.92

10.*

I was able to pick up an object
from the floor without difficulty.

8

0.62

11.*

I needed to nap when I felt tired.

7

0.54

12.

I had enough strength and stamina
to do daily chores or work.

12

0.92

13.

The TPN pump disrupted my
sleep.

13

1.00

14.

My sleep was disrupted because I
had to get up to move my bowels
or empty my ostomy bag.

12

0.92

15.

My sleep was disrupted because I
had to get up to urinate.

13

1.00

16.

I ate comfortably in social
situations and around others.

12

0.92

17.*

Eating caused me to have gas or
feel bloated.

10

0.77

18.*

Eating caused me to have pain.

10

0.77
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Item

Number of
Experts giving a
rating of a “3” or
“4”

k

19.

I had episodes of uncontrollable
diarrhea.

12

0.92

20.*

I had to move my bowels shortly
after I ate food.

10

0.77

21.

I had to rearrange my daily plans
because of how much diarrhea I
had.

12

0.92

22.

I had episodes of uncontrollable
ostomy leakage.

13

1.00

23. *

I had to empty my ostomy bag
shortly after I ate food.

9

0.690

24.

I had to rearrange my daily plans
because of how much ostomy
output I had.

13

1.00

Section 2
1.

Good quality of life means being
able to do what I want to do when I
want to do it.

11

0.85

2.

I eat and enjoy the foods I want to
eat.

11

0.85

3.

I am confident in my ability to
perform TPN procedures on my
own.

13

1.00

4.

Having one or more nights or days
without TPN is important to me.

13

1.00

5.

Having a shorter TPN infusion
schedule is important to me.

13

1.00

13

1.00

12

0.92

13

1.00

6.

7.
8.

I feel relieved knowing my
nutritional needs are being met by
TPN therapy.
I am fearful of developing
complications related to my TPN
therapy and/or central line.
I understand my need for being on
TPN therapy.
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Item
9.

10.

11.

12.

13.

14.
15.
16.

I know and have been
trained on how to manage
my TPN therapy.
I know and have been
trained on how to care for
my central line.
I know and have been
trained on how to use my
pump.
I know and have been
trained on the signs and
symptoms of a central
line infection.
I know and have been
trained on the signs and
symptoms of dehydration.
I know and have been
trained about my diet and
what I should be eating.
I know whom to call
when I have questions
about my TPN therapy.
I feel emotionally
supported by my family
and friends.

Number of Experts
giving a rating of a
“3” or “4”

k

13

1.00

13

1.00

13

1.00

13

1.00

13

1.00

13

1.00

13

1.00

12

0.92

17.

I feel well supported by
my home care specialists.

13

1.00

18.

I received information
about local or national
support groups for TPN
therapy.

13

1.00

19.

I wish I knew more about
my TPN therapy.

12

0.92

NOTE: I-CVI: item-level content validity index, **pc (probability of a chance occurrence) was
computed using the formula: pc= [N! /A! (N -A)!] *.5Nwhere N= number of experts and A=
number of panelists who agree that the item is relevant. Number of experts=14, ***k (modified
kappa) was computed using the formula: K= (I-CVI- PC)/(1- PC). Interpretation criteria for
kappa, using guidelines described in Polit et al. 20an item is considered “excellent” if k >0.780.
Any item not meeting this criterion was deleted from the final HPN-PROQ. *Item
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Appendix A: Literature Review
Introduction
A patient reported outcome (PRO) questionnaire may enhance a clinician’s
awareness of factors influencing a patient’s ability to adapt and cope with receiving
long-term parenteral nutrition as their purpose is to collect quality of life (QoL)
information.1-3 Currently, there is one validated tool to support the Home Parenteral
Nutrition (HPN) population, the Home Parenteral Nutrition Quality of Life
Questionnaire (HPN-QoL)©.4 However, according to published reports, this tool has
only been used in research studies thus far.4-6 For this reason, the Home Parenteral
Nutrition Patient Reported Outcome Questionnaire (HPN-PROQ) was developed for
patients to self-assess aspects of their lives; aspects they may want to consider
discussing with their HPN clinicians. Patient responses on the questionnaire are to be
used to facilitate discussion between the HPN patient and clinician regarding patient
goals and lifestyle adaptation. The aim of this study was to determine the content
validity of the HPN-PROQ though cognitive interviewing with HPN patients and
computing the Content Validity Index (CVI) with HPN expert clinicians.
Content validity must be established as part of the development phase of new
PRO instruments.7 Content validity is defined as the extent to which a new instrument
congruently measures aspects of a patient’s life; this can include aspects both medical
and non-medical in nature.7 This literature review will broadly cover indications of
HPN and QoL with a more in-depth review of the processes involved in PRO
development, the application of cognitive interviewing (CI) and the Content Validity
Index (CVI) in content validation, and the use of PRO instruments in clinical practice.
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Home Parenteral Nutrition
Parenteral nutrition is a complex therapy involving the intravenous infusion of
nutrients and fluids to individuals who have intestinal failure or dysfunction.8 Most
frequently, these patients carry diagnoses of short-bowel syndrome, inflammatory
bowel disease, or cancer with bowel obstruction.9,10 Over the last three decades, the
expansion of home-health and nutrition support agencies have allowed HPN to
become the primary treatment for patients who require long-term parenteral
nutrition.11 Home parenteral nutrition should be used exclusively with patients who
cannot meet their nutritional requirement by enteral intake, and who are able to
receive therapy safely outside the acute care setting.12,13
It is estimated that 33,000 people in the United States required HPN in 2010.14
The likelihood of being weaned from HPN is significantly reduced after 3 years and
20-30% of patients require permanent treatment.15 Home-based care provides patients
the opportunity to a receive complex therapy in a familiar and comfortable
environment, with support from family members and trained healthcare
professionals.16 Furthermore, patients benefit from home-based care as it provides
improved QoL and comes at a lower cost than inpatient parenteral nutrition.16,17
Quality of Life
Quality of life is defined by the Food and Drug Administration (FDA) as a
‘general concept that implies an evaluation of the effect of all aspects of life on
general well-being’.18 Health-related quality of life (HrQoL) is composed of multiple
domains that comprehensively measure the patient's experience of symptoms (i.e.
functional status, and psychosocial elements) against the patient's expectations and to
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quantify the extent to which the burden of disease impacts a patient's quality of life.19
Due to the complex technology of HPN as well as the underlying intestinal disease,
QoL is thought to be poorer in individuals receiving HPN compared to patients with
intestinal diseases who do not require nutritional support.10 Practical daily life
restrictions and physical parenteral nutrition-associated complications may negatively
affect quality of life (QoL).17
Roskott et al.11 determined that although HPN patients have a variety of
different somatic symptoms, psychosocial problems have the greatest negative impact
on QoL. Psychosocial factors include coping with medical diagnosis, being dependent
on technology, coping with the loss of the eating experience, relying on others for
care, low self-esteem, interfering with sexual functions, and enduring the financial
burden of nutrition support.8 Home parenteral nutrition patients also experience
decreased physical, psychological, and social function along with increased
occurrences of depression, drug dependency, sleep disturbance, frequent urination,
fear of therapy-related complications, and inability to eat.8,16,20 All of these factors
may affect the QoL if a HPN patient.
When patients are discharged on HPN, support is available for HPN patients
who are adjusting to HPN dependence outside of the clinical setting. Via membership
of support and educational organizations, such as the Oley Foundation patients can
actively participate in the HPN community, blogs, and research projects, and receive
newsletters and educational information. Studies have shown that membership in such
an organization is valuable the QoL of HPN patients.21,22 The Oley Foundation offers
resources such as education, support groups, and workshops to HPN patients, and their
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caregivers and families clinicians play a key role in introducing their patients to
organizations such as the Oley Foundation.21 In addition to helping patients adjust to
complexities of HPN therapy nutrition support.21 Support in the clinical setting is also
important in the management, success, and quality of life of the HPN patient. Roskott
et al.11 reported on the importance of offering psychosocial and medical support for
fatigue, sleeping disorders, anxiety, depression, and social isolation, to improve QoL.
However, research by Winkler et al.23 demonstrated that HPN patients perceive their
routine medical appointments with their clinicians as a parenteral nutrition “tune-up”,
and reported that with session focus primarily on medical or disease aspects of care.
Patients self-reported they desire a more holistic approach to parenteral nutrition
management, incorporating physical and emotional support, in addition to medical
examination and nutrition assessment.23
Clinicians have serious concerns about the QoL of their HPN patients but are
in need of guidance assessing the nature and severity of individually experienced
problems.24 Baxter et al.24 demonstrated the need for HPN-specific questionnaire to
support the HPN population and subsequently developed the Home Parenteral
Nutrition Quality of Life questionnaire (HPN-QOL©) for the measurement of QoL in
the HPN population. However, the use of this instrument has only been reported in
clinical trials and research studies thus far.4-6 Furthermore, findings from the Sustain™
National HPN Registry demonstrate lack of routine assessment of QoL in the
management and care of HPN patients in the U.S.9
Of difference between the HPN-QOL© and the HPN-PROQ is the HPNQOL© is a scored instrument, i.e. generates a number that can be compared over time
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and/or with other populations (normal/well or disease-specific). The HPN-PROQ does
not produce a score, but instead allows a subjective approach to the evaluation of
issues that may impact QoL. Use of this tool helps patients prioritize specific areas
that they may wish to discuss with their clinicians and allows patients the opportunity
to explain their concerns and qualify why they are feeling the way they are feeling to
their clinician in more detail. The HPN-PROQ is a necessary and novel instrument
which should be used to facilitate communication among HPN patients and their
clinicians to assist in the improvement of patient-care and interventions aimed at
supporting the HPN population.
Patient Report Outcome Instruments
Overall, research within and outside the HPN population strongly supports the
use of PRO’s in clinical practice.24 Patient reported outcomes instruments collect
information from the patient about a health condition and its management, including
QoL constructs.25 Traditional applications of PRO instruments are in clinical research
and health services research, although use in clinical practice is increasing.25 Many
PRO instruments are self-administered questionnaires. They are given directly to the
patient without the intervention of a clinician and without a third party’s
interpretation; making them more reliable than observer-reported measures because
they are not affected by inter-observer variability.18
In the clinical practice setting, PRO instruments are used as screening tools,
monitoring tools, decision aids, and as a method of facilitating communication
amongst multi-disciplinary teams.26 The potential use of PRO instruments in clinical
practice to improve the interactions between patients and their clinicians is
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promising.27 When used in clinical practice, feedback is provided to the clinicians with
the goal of helping them manage patient care.27 Detmar et al.2 found that incorporating
standardized QoL assessments in daily clinical oncology practice facilitated
discussions of HR-QoL issues and heighten physicians' awareness of their patients'
HR-QoL. Two recent trials measured clinician–patient communication and determined
there was an increase in the number of times HR-QoL issues were discussed in the
consultation following PRO feedback.28,29 These discussions could lead to patients
becoming more involved in decisions about their care thereby increasing their selfefficacy to manage their own health.26
Not only have investigators found positive results with the use of standardized
PRO instruments in facilitating patient-clinician communication, they also improve
clinicians’ understanding of patients’ problems--particularly those of a psychosocial
nature.25 Provision of PRO feedback to clinicians also results in an increase use of
health services and referrals, more timely reporting and management of symptoms,
less patient anxiety, fewer preventable emergency room and office visits or calls,
greater patient adherence to advice, greater satisfaction with care, more effective selfmanagement, and more efficient use of resources.30,31,32 Having information on
patients’ functioning and well-being alongside their laboratory results, imaging
studies, and treatment notes, allows clinicians to see a more complete picture of the
patient’s status.27
Development of New PRO Instruments
This process begins with item generation based upon data from literature
review, focus groups, or interviews with paitent.18 It should be noted that PRO
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instrument item generation is incomplete without patient involvement, and should
incorporate a wide range of patients to represent variations in severity and in
populations characteristics such as age and sex.18 Keeping in mind the broader patientcentered philosophy, collaboration with the target population in early development and
validation stages can ensure effective handling of sensitive content, and possibly
prevent attrition that could result from invasive or offensive content.33 The US Food
and Drug Administration also highlights the importance of including substantial
patient input in PRO development.18 Choice of data collection method and choice of
recall period typically follow item generation and is usually determined according to
the intended purpose of the questionnaire.18 The rationale for choosing these
components should be evaluated; showing consideration for a patients ability to
accurately recall the information requested, the characteristics of the disease/condition,
and the treatment received.18
Choice of response options should include clear wording, clear distinction
between choices, be appropriate for the target population, and come with adequate
instructions. Ceiling and floor effects should be kept in mind, and avoided. Response
options should also avoid directional bias.18 Use of VAS in the clinical setting with
self-administered questionnaires is common.34 Baxter et al.24 found that QoL
questionnaires currently being used in the HPN population can be grouped into three
categories; generic and applicable to a rand of diseases of populations; those which are
disease specific, and those which are non-validated. Of the three validated tools in this
study (Short Form 36, EuroQol EQ5D, and the Sickness Impact Profile), all make use
of a VAS.24 Visual Analog Scales are frequently used to evaluate pain, mood, and
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patient satisfaction, and are advantageous in that they are less vulnerable to bias from
confounding factors linked to Likert scales (i.e. ambiguity of response
descriptors/options) and require less time to complete.35 Visual analog response scales
makes questionnaires a more “user-friendly” instrument for both patients and
clinicians. 35 Lastly, in pain assessment, VAS scales are more sensitive and a better
measure of magnitude than descriptive scales. The Irritable Bowel Disease Control
questionnaire also utilizes a VAS.
Content Validation
Validation of newly developed instruments is a rigorous process which
includes the establishment of content validity.7 The importance of content validity in
developing PRO instruments is emphasized by both the US Food and Drug
Administration and the European Medicines Agency18,36. The International Society for
Pharmacoeconomics and Outcomes Research (ISPOR) Board of Directors approved
the formation a the Patient Reported Outcomes Content Validity Good Research
Practices Task Force to develop a good research practices report addressing methods
for documenting the content validity of newly developed questionnaires7.
When testing the content of a newly developed PRO, there are two primary
components of importance.37,38 First, what is the intent of the question: what do
respondents believe the question is asking? Second is the meaning of specific terms in
the instrument: what do specific words and phrases in the instructions, items, and/or
response options mean to respondents? Is that meaning consistent with the intent of
the researchers? Is it relevant to the concept of interest? Does it raises new content
important to the concept of interest and/or new content not reflected in the instrument
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as it is currently designated? If problems are identified, this will result in the revision
of the draft instrument, followed by a new round of cognitive interviewing to test said
revesions.38
Cognitive Interviewing
After item generation, reporting evidence of content validity for a new PRO
should be address in the processes taken for gathering evidence that persons in the
target population understand the instruments structure and content. Patient-reported
outcome questionnaires must include concepts and language relevant to patients and
be easily understood. To improve content validity specifically, PRO instruments
should utilize common terms understood by the target population. The technique of
cognitive interviewing (CI) can be used to conduct a systematic, in-depth approach in
assessing the validity of a questionnaire’s content and instructions. Cognitive
interviewing is an evidence-based technique to assist researchers in providing content
validity-evidence by assessing the participants interpretation of items during
interviews.39 This process is often done as part of preliminary development, in the
pretesting phase, prior, and to distribution in the field.33,40-44 This method is employed
to test the relevance, comprehension, sensitivity, and the acceptability of the items.40
Overall, this process and analysis allows researchers to demonstrate that the new PRO
instrument is understandable to potential respondents.
Cognitive interviewing can minimize errors arising from respondents’
misunderstanding during data collection by assessing clarity of terminology, phrasing
and format and is considered most valuable in pretesting complex questions and where
questions might be sensitive and intrusive.42 Individual interviews are used within the
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target population using techniques such as think aloud and /or verbal probing to
ascertain exactly how an item is interpreted and how a response is formed.7 Semistructured interviews are recommended method for developing QoL questionnaires
where lay people are involved.45 Cognitive interviews are audio recorded and
transcribed verbatim and results are presentment in summary of essential findings,
including representative quotations for each item or concept tested.7
Interview data serves to assist researchers in identifying problematic questions
that may elicit response error and verify the relevance of item content to the target
population.41,42 Findings from these interviews are reviewed and interpreted by the
researcher, and modification/revisions are incorporated into the instrument.41 Key
findings show whether items or scales on the questionnaire deviate from what is
expected by the survey developers, or identify items, response scales, or instructions
requiring modification. The revised instrument is often tested in further rounds until
data saturation is achieved.41
Addressing all concerns and suggestions made by every participant is not
possible, however demonstration that the new PRO instrument is understandable to
potential respondents is essential in evaluation of content validity.7 It is important to
recognize that data collected from cognitive interviews are qualitative in nature, and
are mainly used to assess and improve questionnaire items before the questionnaire is
implemented.42 Cognitive interviewing requires a level of understanding of patient
issues alongside the ability to listen, interpret, and accurately report patient comments;
all of which are not reflected in quantitative research.46
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Cognitive interviews have been used in several areas in health care research to
pretest and validate questionnaire and to ensure high response rates and can be highly
effective in developing questionnaires.42 Generally, small numbers of patients are
selected, usually between 5 and fifteen, to complete a round of interviewing.
6,41,46,47,48,49

Baxter et al.4 used a cognitive debriefing questionnaire asking patients

eight generic questions to identify general content validity issues with the HPNQOL. Patients were asked if they thought any of the questions were irrelevant, or
problematic. Researchers collaborated with patients in the development of the
Rheumatoid Arthritis fatigue PRO questionnaire by using qualitative interview data to
strengthen face and content validity of a draft conceptual framework. In this process,
the researchers ensured comprehension of the PRO by the target population.49
Schildmann et al.50 used cognitive interviewing in the first phase of a validation study
of the Integrated Palliative care Outcome Scale, which proved to be valuable to
increase content validity of the questionnaire. Additionally, in the development and
validation of a new PRO for patients with pressure ulcers, cognitive interviews were
used to identify problems with item content (i.e. ambiguous or confusing).51
It must be noted that cognitive interviews have been criticized for being overly
subjective and artificial.42 However, rigor in qualitative research can be accomplished
by having a “sound scientific methodology” and protocol, which includes semistructured interview scripts, appropriate analysis of the data and documentation of the
findings.46

50

The Content Validity Index
Instrument content validity is often established through qualitative review
alongside quantitative analysis of reviewer agreements.52 The use of quantitative data
in the absence of thorough collection of knowledge, frameworks, and qualitative
considerations can lead to a theoretical instrumentation producing scores with
unknown meaning. It also should be recognized that the use of qualitative data alone
to substantiate an instrument may be rhetorically convincing, but scientifically
incomplete.7
In reports of instrument development, the most widely reported approach for
content validity is the Content Validity Index (CVI).53,54 According to Polit et al.55, the
CVI is the most widely used method of quantifying content validity for multiple item
scales among nurse researchers.
The CVI is based on expert ratings of relevance, and is used for quantifying
content validity for scales.55 A CVI value can be computed for each item on a scale (ICVI) as well as for the overall scale content validity average (S-CVI/AVG).55 The ICVI is calculated by having experts in the field of interest rate the relevance of each
item to its own subdomain.56 A 4-point ordinal scale is used and expert panel members
are asked to rate the item’s relevance to the construct of interest (i.e. 1:not relevant,
2:somewhat relevant, 3:quite relevant, and 4:hightly relevant). The number of those
judging the item as relevant (rating of 3 or 4), are divided by the number of experts on
the panel.57 Although the CVI is used to determine content validity, this index does
not consider the chance agreement. Wynd et al.52 proposed using both the multi-rater
kappa statistic alongside the CVI to account for chance agreements.
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Calculating the S-CVI/AVG is done by first computing the I-CVI for each item on the
scale and then by calculating the average I-CVI across items.55
In the development and content validation of an instrument measuring patientcentered communication, fourteen designated experts completed the CVI using a
modified kappa statistic to quantify item relevance.58 In this study, the researchers
used a CVI criteria of .70 for item retention; resulting in the removal of 4 items from
their prototype questionnaire as the result of this method. In a smaller sample (n=9),
Larsson et al.59 used the CVI in the validation of muscle endurance questionnaire
using a I-CVI score of ≥.78 to indicate “excellent” relevance; resulting in the deletion
of fourteen items. To determine the content validity of The Osteoporosis Risk
Assessment Tool (ORAT), eight experts were selected from nationally known
clinicians and researchers holding well-respected reputations in the area of
osteoporosis risk prevention and treatment.60 This study used an acceptable level of
relevance score of .58 to determine item relevance and criteria for the deletion or
retention of items on a draft questionnaire.60 Overall, the CVI is valuable to
researchers because of its simplicity and its ability to provide information about each
item, which then can be used for modification or deletion of instrument items.55,57
Once content validity is established and is ready for pilot testing, respondent
burden should be assessed for undue physical, emotional, or cognitive strain. The time
to complete the questionnaire should be adequate and efficient.18
Psychometric Validation
As a final stage in instrument development, PRO measurement properties
should be assessed for reliability (test-re-test), validity, ability to detect change, and
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the interpretability (e.g. minimum important difference).18 Any indication for
modification to the instrument following these steps should be addressed.18
Translation of PROMs into other languages should also be completed in the
development process of all PRO questionnaires. This involves establishing conceptual
and semantic equivalence and should include forward and backward translation
methods, plus an assessment of the translated questionnaire’s measurement
properties.61 However, most PROMs are not available in a variety of different
languages because of the costly nature of such a project. 61 This is problematic in
healthcare settings because diverse cultures and language preferences are prevalent.
Having a relative or friend to translate the questionnaire for the patient is not
acceptable, as maintaining the correct meaning in the exchange cannot be
guaranteed.61
PRO’s in Clinical Practice
The use of PRO measures might seem quite straightforward; however, a
number of pitfalls await clinicians with limited expertise. Defining the different
applications of PRO instruments in clinical practice is difficult because of its complex
nature and the heterogeneous methodology across PRO studies. These studies differ in
what type of PRO they use, how the information is fed back, and whom it is fed back
to.26 However, it is known that PRO instruments can enhance patient–clinician
communication and inform plans of care to better target interventions that will
improve patient outcomes.30, 31 Evidence supporting positive associations between
physician communication behaviors and positive patient outcomes is strong. Such
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outcomes include: patient ability to recall information, increase in patient
understanding, and patient adherence to therapy.
There is also consensus on what constitutes “best practice” for physician
communication in medical encounters (i.e. fostering the relationship, gathering
information, providing information, making decisions, responding to emotions, and
enabling disease-and treatment-related behavior).62 This is especially important as
patients and doctors do not always agree on which outcomes of care are most
significant. For example, patients with multiple sclerosis, and possibly those with
other chronic diseases, reported being less concerned than their clinicians about
physical disability and are more concerned with issues impacting their QoL.63
According to Dawsons et al.61, there are very few published examples of the
application of PRO’s in the context of clinical practice and quality assurance, and little
evidence of the impact of using PRO’s in routine practice is lacking. Because there are
a number of relevant questionnaires to choose from, clinicians can be challenged with
determining the appropriate questionnaire for their intended purpose. Alternatively,
some questionnaires may seem entirely inappropriate and may contain items that are
irrelevant to the target population. For this reason, the development of a treatment and
disease specific PRO instruments is an important in fostering a increase in the use of
PRO’s in clinical practice.
Evidence from randomized controlled trials suggests that the use of PROs in
clinical practice is valuable in improving the discussion and detection of QoL
constructs, but has less of an impact on how clinicians manage patient problems or on
subsequent patient outcomes.26 Many of the reasons for this may lie in the ways in
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which PROs fit (or do not fit) into the routine ways in which patients and clinicians
communicate with each other, how clinicians make decisions, and how healthcare is
organized. Greenhalgh et al. 26 suggests future research should seek to identify ways in
which PROs can be better incorporated into the routine care of patients by combining
qualitative and quantitative methods.
Regardless, use PRO instruments can provide several advantages; as a means
to alert the clinician to the patient’s concerns about their QoL, to clarify via discussion
the patient’s priorities for care, and to facilitate conversation between patients and
clinicians about these issues.3 These positive outcomes and processes in patient care
could lead to increased patient satisfaction.64 Use of PRO’s in clinical practice could
also increase patient satisfaction by promoting patient-centered care. Domains used to
assess patient satisfaction with care includes “communication and relationships”, and
PRO instruments serve to foster improved communication between the patient and the
clinician.65 In conclusion, this literature review supports the development of a PRO
questionnaire for the HPN population could have a positive impact on patient-clinician
communication, patient care and satisfaction, and overall quality of life.48
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Appendix B: Draft HPN-PROQ
Home Parenteral Nutrition Patient Reported Outcomes Questionnaire
(HPN-PRO-Q)

Patient Instructions:
This questionnaire is intended to help you identify areas of concern or problems with
your home TPN over the last 2 weeks that may affect your quality of life and/or your
ability to do the things you would like to do. These patient-reported outcomes (PRO)
may be used to prioritize what you would like to discuss with your physician, health
care professional, or members of your home parenteral nutrition management team as
well as set goals for your care.
Healthcare Professional Instructions: The responses on this questionnaire are
intended to facilitate discussion between patient and practitioner regarding patient
goals related to home TPN and lifestyle adaptation.
TPN = total parenteral nutrition

During the past 2 weeks, how often have
you experienced any of the following
situations?
1
2
3
4
5
6
7
8
9
10
11
12
13

I eat and enjoy the foods I want to eat.
I can participate comfortably in social
situations where food is served.
Eating causes me to have gas or feel
bloated.
Eating causes me to have pain.
I am able to live what I consider a
normal lifestyle.
I feel emotionally supported by my
family and friends.
I feel like my medical condition
controls my life.
Being on TPN is difficult to cope with.
My TPN schedule limits my freedom
to participate in daily activities.
Carrying my TPN solution limits what
I can do.
I am confident with my ability to
perform TPN procedures on my own.
I feel physically strong.
I am able to take care of myself.
61

Two to More
three than
Not at
days
half
all
per
of
week
days

Nearly
every day

14 I am able to participate in the activities
I enjoy.
15 I am able to walk without difficulty.
16 I am able to climb up and down stairs
without difficulty.
17 I am able to rise from a chair or bed
without difficulty.
18 I am able to pick up an object from the
floor without difficulty.
19 I need to nap when I feel tired.
20 I have enough strength and stamina to
do daily chores or work.
21 I am satisfied with the amount I sleep
at night.
22 The TPN pump disrupts my sleep.
23 My sleep is disrupted because I have to
get up to move my bowels or change
my ostomy appliance.
24 My sleep is disrupted because I have to
get up to urinate.
***Please answer these questions if you DO NOT have an end-jejunostomy or
ileostomy BUT DO HAVE bowel in continuity. ***
During the past 2 weeks, how often have
you experienced any of the following
situations?
25 I move my bowels many times during
the day.
26 I move my bowels many times during
the night.
27 I have to move my bowels urgently.
28 I have episodes of uncontrollable
diarrhea.
29 I have to move my bowels as soon as I
eat food.
30 I plan my daily activities around how
much diarrhea I have.
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Not at
all

Two to
three
days per
week

More
than
half of
days

Nearly
every
day

***Please answer these questions if you DO HAVE an end-jejunostomy or ileostomy.
During the past 2 weeks, how often have
you experienced any of the following
situations?

Not at
all

Two to
three
days per
week

More
than
half of
days

Nearly
every
day

31 I empty my ostomy appliance many
times during the day.
32 I empty my ostomy appliance many
times during the night.
33 I have to empty my ostomy appliance
urgently.
34 I have episodes of uncontrollable
ostomy leakage.
35 I have to empty my ostomy appliance
as soon as I eat food.
36 I plan my daily activities around how
much ostomy output I have.
How TRUE or FALSE is each of
the following statements for you?
1 Good quality of life means
being able to do what I want
to do when I want to do it.
2 Having one or more nights
without TPN is important to
me.
3 Having a shorter TPN
infusion schedule is
important to me.
4 I feel relieved knowing my
nutritional needs are being
met by TPN.
5 I do not need to eat because I
receive TPN.
6 I am fearful of developing
complications related to my
catheter.
7 I am fearful of developing
complications related to TPN.
8 I understand the need for
being on TPN.
9 I am informed and well
trained about managing my
TPN.

Definitely
True
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Mostly
True

Mostly
False

Definitely
False

10

11
12

13

14
15

16
17

18

I am informed and well
trained about the care of my
catheter.
I am informed and well
trained about using my pump.
I am informed and well
trained about signs and
symptoms of infection.
I am informed and well
trained about signs and
symptoms of dehydration.
I understand my diet and
what I should be eating.
I know whom to call when I
have questions about my
TPN.
I feel well supported by my
home care specialists.
I received information about
local or national support
groups for TPN.
I wish I knew more about my
TPN.
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Appendix C: Final HPN-PROQ

HPN-PROQ
Home Parenteral Nutrition Patient Reported Outcomes Questionnaire

Patient Instructions:
This questionnaire is intended to help you identify areas of concern or problems with
your home TPN over the last 2 weeks that may affect your quality of life and/or your
ability to do the things you would like to do. These patient-reported outcomes (PRO)
may be used to prioritize what you would like to discuss with your physician, health
care professional, or members of your home parenteral nutrition management team as
well as set goals for your care.
Healthcare Professional Instructions: The responses on this questionnaire are
intended to facilitate discussion between patient and practitioner regarding patient
goals related to home TPN and lifestyle adaptation.
“TPN” = total parenteral nutrition solution/formula.
“TPN therapy” = procedures/equipment/devices necessary to administer the TPN
solution/formula

HPN Consumers: Please place a “X” on the dotted line where it most clearly indicates
the frequency of occurrence for each of the given situations over the past two weeks.

During the past 2 weeks, please estimate how often you experienced any of the
following situations.
1.

I felt like my health limited the things I want to do in my life.
Not at all ----------------------------------------|-------------------------------------- Every day

2.

Being on TPN was difficult to cope with emotionally.
Not at all ----------------------------------------|-------------------------------------- Every day
- Please continue to the next page -
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During the past 2 weeks, please estimate how often you experienced any of the
following situations.
3.

My daily activities were limited by my TPN infusion schedule.
Not at all ----------------------------------------|-------------------------------------- Every day

4.

I was able to participate in the activities I enjoy.
Not at all ----------------------------------------|-------------------------------------- Every day

5.

I was able to walk without difficulty.
Not at all ----------------------------------------|-------------------------------------- Every day

6.

I was able to rise from a chair or bed without difficulty.
Not at all ----------------------------------------|-------------------------------------- Every day

7.

I had enough strength and stamina to do daily chores or work.
Not at all ----------------------------------------|-------------------------------------- Every day

8.

The TPN pump disrupted my sleep.
Not at all ----------------------------------------|-------------------------------------- Every day

9.

My sleep was disrupted because I had to get up to move my bowels or empty my
ostomy bag.
Not at all ----------------------------------------|-------------------------------------- Every day

10. My sleep was disrupted because I had to get up to urinate.
Not at all ----------------------------------------|-------------------------------------- Every day
11. I ate comfortably in social situations and around others.
Not at all ----------------------------------------|-------------------------------------- Every day
- Please continue to the next page -
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***Answer questions 12 &13 if you do NOT have an end-jejunostomy or ileostomy
but do have bowel in continuity. ***
12. I had episodes of uncontrollable diarrhea.
Not at all ----------------------------------------|-------------------------------------- Every day
13. I had to rearrange my daily plans because of how much diarrhea I had.
Not at all ----------------------------------------|-------------------------------------- Every day

***Answer questions 14-16 if you HAVE an end-jejunostomy or ileostomy. ***
During the past 2 weeks, please estimate how often you experienced any of the
following situations.
14. I had episodes of uncontrollable ostomy leakage.
Not at all ----------------------------------------|-------------------------------------- Every day
15. I had to empty my ostomy bag shortly after I ate food.
Not at all ----------------------------------------|-------------------------------------- Every day
16. I had to rearrange my daily plans because of how much ostomy output I had.
Not at all ----------------------------------------|-------------------------------------- Every day
- Please continue to the next page -
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How TRUE or FALSE are the following statements to you?
1.

Good quality of life means being able to do what I want to do when I want to do it.
Definitely false ----------------------------------|------------------------------- Definitely true

2.

I eat and enjoy the foods I want to eat.
Definitely false ----------------------------------|------------------------------- Definitely true

3.

I am confident in my ability to perform TPN procedures on my own.
Definitely false ----------------------------------|------------------------------- Definitely true

4.

Having one or more nights or days without TPN is important to me.
Definitely false ----------------------------------|------------------------------- Definitely true

5.

Having a shorter TPN infusion schedule is important to me.
Definitely false ----------------------------------|------------------------------- Definitely true

6.

I feel relieved knowing my nutritional needs are being met by TPN therapy.
Definitely false ----------------------------------|------------------------------- Definitely true

7.

I am fearful of developing complications related to my TPN therapy and/or central
line.
Definitely false ----------------------------------|------------------------------- Definitely true

8.

I understand my need for being on TPN therapy.
Definitely false ----------------------------------|------------------------------- Definitely true

9.

I know and have been trained on how to manage my TPN therapy.
Definitely false ----------------------------------|------------------------------- Definitely true
- Please continue to the next page -
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How TRUE or FALSE are the following statements to you?
10. I know and have been trained on how to care for my central line.
Definitely false ----------------------------------|------------------------------- Definitely true
11. I know and have been trained on how to use my pump.
Definitely false ----------------------------------|------------------------------- Definitely true
12. I know and have been trained on the signs and symptoms of a central line infection.
Definitely false ----------------------------------|------------------------------- Definitely true
13. I know and have been trained on the signs and symptoms of dehydration.
Definitely false ----------------------------------|------------------------------- Definitely true
14. I know and have been trained about my diet and what I should be eating.
Definitely false ----------------------------------|------------------------------- Definitely true
15. I know whom to call when I have questions about my TPN therapy.
Definitely false ----------------------------------|------------------------------- Definitely true
16. I feel emotionally supported by my family and friends.
Definitely false ----------------------------------|------------------------------- Definitely true
17. I feel well supported by my home care specialists.
Definitely false ----------------------------------|------------------------------- Definitely true

18.

I received information about local or national support groups for TPN therapy.
Definitely false ----------------------------------|------------------------------- Definitely true
- Please continue to the next page -
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How TRUE or FALSE are the following statements to you?
19.

I wish I knew more about my TPN therapy.
Definitely false ----------------------------------|------------------------------- Definitely true

Thank you for completing the
Home Parenteral Nutrition Patient Reported Outcomes Questionnaire
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Appendix E: Recruitment Materials
Flyer for Oley Foundation Website/Newsletter/Email
Volunteers Wanted for Research Study
To participate in the development of a new questionnaire created to serve the
Home Parenteral Nutrition (HPN) Population.

This is a URI research study, the principle investigator is Dr. Geoffrey Greene. The
purpose of this study is to assess the content validity of the Home Parenteral Nutrition
Patient Reported Outcome Questionnaire (HPN-PRO-Q). This questionnaire is
intended to be used in clinical practice by patients to self-assess factors that influence
quality of life or adaptation to HPN. We intend to evaluate a questionnaire about HPN
and quality of life that may be used in the future to start a conversation about your
quality of life with your doctor or HPN management team.
You will be asked to participate in a interview via telephone so that we may assess
your individual understanding and comprehension of the questions included on the
HPN-PRO-Q. The interviewer will be located in be in a private office located at the
University of Rhode Island Kingston, RI- Fogerty Hall, office 103. The interview
should take about one hour or longer, depending on how much you want to speak
about each item on the questionnaire. Our conversation will be kept completely
confidential and your responses will remain confidential.
There is no direct benefit to you. It is hoped that the information from the interview
will lead to a better understanding of the relevance, comprehension, and
appropriateness of each question in the HPN-PRO-Q.
This research has been approved by the University of Rhode Island (URI) Institutional
Review Board (IRB).
To be eligible you must:
• Receive home parenteral nutrition.
• Be willing to speak about your experiences living with home parenteral
nutrition.
• Be over 18 years-old.
• Live in the United States
• Have computer access, an active email address, access to the internet, and a
telephone you can access while simultaneously using your computer.
• Be English speaking.
Confidentiality of all information will be maintained. This study will take place from
June-November 2016.
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For more information or to indicate your interest in participating in the study, email
Tracy Miller at HPN-PRO@etal.uri.edu. Please include your name, telephone number
with area code, email address, and best time to reach you.

Thank you for considering to participate in this research study!
The University of Rhode Island
Department of: Department of Nutrition and Food Sciences
Content Validity of Home Parenteral Nutrition Patient Reported Outcome
Questionnaire
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Expert Panel I-CVI, S-CVI Recruitment Letter/Email
Volunteers Wanted for Research Study
To participate in the development of a new questionnaire created to serve the
Home Parenteral Nutrition Population
We are looking for the following persons:
• Home parenteral nutrition clinicians, physicians, nurses
• Homecare advocates
• Registered dietitians
This is a URI research study; the principle investigator is Dr. Geoffrey Greene. The
purpose of this study is to assess the content validity of the Home Parenteral Nutrition
Patient Reported Outcome Questionnaire (HPN-PRO-Q). This questionnaire is
intended to be used in clinical practice by patients to self-assess factors that influence
quality of life or adaptation to HPN. This assessment is meant to facilitate a
conversation between health-care providers, the patient, and other members of the
home nutrition care team. This research is being conducted in collaboration with
Marion Winkler, PhD, RD, LDN, CNSC.
We are looking for experts in the field of HPN. If you are a HPN clinician,
physician, homecare advocate, nurses, and/or a dietitian you are eligible to
participate in this study. We are looking for your feedback on the HPN-PRO-Q, as it is
valuable in the development of this instrument.
We will be asking you to complete the Content Validity Index (CVI). The itemlevel Content Validity Index (I-CVI) is calculated by having experts in the field of
interest rate the relevance of each item to its own subdomain. The item-level Content
Validity Index (I-CVI) is calculated by having the experts rate the relevance of each
item to its own subdomain. (1=not relevant, 2=somewhat relevant, 3=quite relevant,
4=highly relevant.)
If you agree to participate, you will be sent a CVI-Worksheet via email. Upon
completion of the worksheet, you will be asked to save your work as a PDF and return
it to the research email address.
This process should take approximately 20 minutes. Pending your availability, you
may be asked to complete an additional round of the I-CVI after revisions to the
instrument are made. This process should take an approximately and additional 20
minutes.
Confidentiality of all all information will be maintained. This research has been
approved by the University of Rhode Island’s (URI) Institutional Review Board
(IRB).
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There is no direct benefit to you for participating in the study. It is hoped that the
information you provide will lead to a better understanding of the relevance of the
items included on the HPN-PRO-Q.
For more information or to indicate your interest in participating in the study, email
Tracy Miller at HPN-PRO@etal.uri.edu. Please include your name, telephone number
with area code, email address, and best time to reach you.
Thank you for considering to participate in this research study.
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HPN Patient-Cognitive Interview Screener Email
Dear Mr. or Ms._________,
Thank you for your interest in this study. This is a URI research study, the principle
investigator is Dr. Geoffrey Greene. The purpose of this study is to assess the content
validity of the Home Parenteral Nutrition Patient Reported Outcome Questionnaire
(HPN-PRO-Q). This questionnaire is intended to be used in clinical practice by
patients to self-assess factors that influence quality of life or adaptation to HPN. There
is no direct benefit to you. It is hoped that the information from the interview will lead
to a better understanding of the relevance, comprehension, and appropriateness of each
question in the HPN-PRO-Q.
This research has been approved by the University of Rhode Island (URI) Institutional
Review Board (IRB).
In order to determine if you are eligible to participate, please answer the following
questions and return by email within the next 3 days. If you have any questions,
please contact the research team @ HPN-PRO@etal.uri.edu.
Criteria for Participation
Do you live in the US?
What is your age in years?
Are you pregnant?
Are you receiving home TPN?
Do you speak English?
Do you have computer access?
Can you talk on the telephone and read on the computer at the same time?
You will be asked to participate in a 60-90 minute interview via telephone so that we
may assess your individual understanding and comprehension of the questions
included on the HPN-PRO-Q. The interviewer will be located in be in a private office
located at the University of Rhode Island Kingston, RI- Fogerty Hall, office 103.
Please send responses to HPN-PRO@etal.uri.edu
You will be hearing from me by [Date]
Thank you and I am looking forward to working with you!

Sincerely,
Tracy-Lee Miller,
Graduate Student in Food Science and Nutrition
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Introduction
Hello,
My name is Tracy. I am a graduate student at the University of Rhode Island. Thank
you for participating in this study. The purpose of this study is to evaluate a
questionnaire about HPN and quality of life that may be used in the future to start a
conversation about your quality of life with your doctor or HPN management team.
This questionnaire is called the Home Parenteral Nutrition Patient Reported Outcomes
Questionnaire (HPN-PRO-Q) for short. I appreciate the time you’ve set aside to speak
with me about your experiences on home parenteral nutrition and living with nutrition
support.
Before we begin, I want to review a few things with you.
Your participation in this interview is completely voluntary; you may choose not to
participate.
If there are any questions you do not wish to answer, just let me know and we can skip
it.
You can stop the interview at any time.
The interview should take about one hour or longer, depending on how much you
want to speak about each item on the questionnaire. Our conversation will be kept
completely confidential and your responses will remain anonymous.
I am in a private office and will be using a speakerphone. No one else will be in the
room with me.
If you agree, our conversation will be tape-recorded in order to document your exact
words. The tapes will be destroyed at the end of this project. The transcripts will be
numbered and will not contain your name or any identifying information.
There is no risk to you by answering these questions. There is no direct benefit to you.
It is hoped that the information from the interview will lead to a better understanding
of the relevance, comprehension, and appropriateness of each question in the HPNPRO-Q.
Your comments will be combined with other study patients when the results are
analyzed. Nothing you tell me will be presented or published in a way that someone
could identify you.
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Do you have any questions about the information we discussed?
I will be turning the tape recorder on now. Do I have permission to tape this
conversation?
--This interview should take about 1 hour. Please let me know if you need to take a
break, would like to end the interview, or prefer to skip a question.

The first couple of questions are about your TPN.
What is your diagnosis relating to your need for home TPN?
How long have you been receiving home parenteral nutrition?
What is your number of home TPN infusion days/hours per week?

Now, I am going to read you 30 statements and ask you what the statement means to
you. I may ask you to repeat the statement in your own words. I may ask you what a
specific term or word means to you. All of the statements will ask you to recall how
often you experienced the symptom or feeling in the past 2 weeks. I may ask you how
you remember that you felt that way.
The first questions I am going to ask you are about how often something or an
event happens to you in a 2-week period.
In a 2 week time frame, what does the response "not at all" mean to you?
In a 2 week time frame, what does the response "2-3 days per week " mean to you?
In a 2 week time frame, what does the response "" more than half the day mean to
you?
In a 2-week time frame, what does the response "nearly every day" mean to you?
The next few questions are about eating. Tell me what you are thinking when I
read the statement to you:
I eat and enjoy the foods I want to eat.
Please repeat the statement I just read to you in your own words.
Would this be easy or hard to answer?
What does "eat" mean to you?
What does "enjoy foods" mean to you?
Would you be able to remember how many times you enjoyed eating food in the past
2 weeks?
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How do you remember how often you experienced enjoying the foods you want to eat
in the past 2 weeks?
I can participate comfortably in social situations where food is served.
Please repeat the statement I just read to you in your own words.
Would this be easy or hard to answer?
What does "social situation" mean to you?
What does "around others" mean to you?
Would you be able to remember how many times you comfortably ate in social
situations or around others in the past 2 weeks?
How do you remember how often you experienced you comfortably ate in
social situations or around others in the past 2 weeks?
Eating causes me to have gas or feel bloated?
Please repeat the statement I just read to you in your own words.
Would this be easy or hard to answer?
What does "gas" mean to you?
What does "bloated" mean to you?
Would you be able to remember how many times eating caused gas or made
you bloated in the past 2 weeks?
How do you remember how often you experienced gas or felt bloated in the
past 2 weeks?
Eating causes me to have pain?
Please repeat the statement I just read to you in your own words.
Would this be easy or hard to answer?
What does "pain" mean to you?
Would you be able to remember how many times eating caused pain in the past
2 weeks?
How do you remember how often you experienced had pain while eating in the
past 2 weeks?
The next few questions are about your lifestyle. Tell me what you are thinking
when I read the statement to you:
I am able to live what I consider a normal lifestyle.
Please repeat this statement in your own words.
Would this be easy or hard to answer?
What does the term "normal lifestyle" mean to you?
Would you be able to answer how often in the last 2 weeks you were able to
live a normal lifestyle?

79

Appendix F: Oral Consent Script and Interview Guide

I feel emotionally supported by my family and friends.
Please repeat this statement in your own words.
Would this be easy or hard to answer?
Who are you referring to when I ask about feeling emotionally supported by
“family”?
Who are you referring to when I ask about “friends” emotionally supporting
you?

I feel like my medical condition controls my life.
Please repeat this statement in your own words?
Would this be easy or hard to answer?
What does the term "medical condition" mean to you?
What does the concept "control your life” mean to you?
Would you be able to remember how many times you felt controlled by your
medical condition in the past two weeks?

The next few questions are about your TPN or [patients name for nutrition
therapy].
Tell me what you are thinking when I read the statement to you:
Being on TPN [or patient’s name for nutrition therapy] is difficult to cope with.
Please repeat this statement in your own words.
Would this be easy or hard to answer?
What does the term "cope" mean to you?
Would you be able to remember how many times in the past 2 weeks TPN was
difficult to cope with?
My TPN schedule limits my freedom to participate in daily activities?
Please repeat this statement in your own words.
Would this be easy or hard to answer?
What does “TPN schedule” mean to you?
What does “limit my freedom” mean to you?
What does “daily activities” mean to you?
Would you be able to remember how many times your TPN schedule limited
your daily activates in the past 2 weeks?
Carrying the TPN solution limits what I can do.
Please repeat this statement in your own words.
Would this be easy or hard to answer?
What does the term “TPN solution” mean to you?
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What does “limits” mean to you?
Would you be able to remember how many times carrying your TPN solution
limited what you wanted to do in the past 2 weeks?
I am confident with my ability to perform TPN procedures on my own?
Please repeat this statement in your own words.
Would this be easy or hard to answer?
What does it mean to you to be "confident"?
What does "perform TPN procedures" mean to you?
What TPN procedures do you perform by yourself?
Would you be able to remember how many times you performed TPN
procedures by yourself in the past 2 weeks?
The next questions are about your energy level and strength. Tell me what you
are thinking when I read the statement to you:
I feel physically strong.
Please repeat this statement in your own words.
Would this be easy or hard to answer
What does it mean to you to be "physically strong"?
Would you be able to remember how many times you felt physically strong in
the
past 2 weeks?
I am able to take care of myself.
Please repeat this statement in your own words.
Would this be easy or hard to answer?
What does "able to take care of yourself" mean to you?
Would you be able to remember how many times you were able to take care of
yourself in the past 2 weeks?
I am able to participate in the activities I enjoy.
Please repeat this statement in your own words.
Would this be easy or hard to answer?
What “activities” would you be referring to if you were answering this
question?
Would you be able to remember how many times you were able to enjoy the
activities you listed above in the past 2 weeks?
I am able to walk without difficulty.
Please repeat this statement in your own words.
Would this be easy or hard to answer?
What does “without difficulty” mean to you?
Would you be able to remember how many times you were able to walk

81

Appendix F: Oral Consent Script and Interview Guide

without difficulty in the past 2 weeks?
I am able to climb up and down stairs without difficulty.
Please repeat this statement in your own words.
Would this be easy or hard to answer?
Do you have stairs you need to climb in your home?
What does “without difficulty” mean to you?
Would you be able to remember how many times you climbed the stairs
without
difficulty in the past 2 weeks?
I am able to rise from a chair or bed without difficulty.
Please repeat this statement in your own words.
Would this be easy or hard to answer?
What does “rise without difficulty” mean to you?
Would you be able to remember how many times in you got out of bed or chair
without difficulty the past 2 weeks?
I am able to pick up an object from the floor without difficulty.
Please repeat this statement in your own words.
Would this be easy or hard to answer?
What does the term “object” mean to you?
What does without difficulty” mean to you?
Would you be able to remember how many times you were able to pick up a
object from the floor in the past 2 weeks?
I need to nap when I feel tired.
Please repeat this statement in your own words.
Would this be easy or hard to answer?
What does “nap” mean to you?
What does “feel tired” mean to you?
Would you be able to remember how many times you napped in the past 2
weeks?
I have enough strength and stamina to do daily chores or work.
Please repeat this statement in your own words.
Would this be easy or hard to answer?
What does “enough” mean to you?
What does “strength” mean to you?
What does “stamina” mean to you?
What do “daily” chores mean to you?
Do you work? What do you do for work?
Would you be able to remember how many times you had enough stamina to
do daily chores or work in the past 2 weeks?
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The next few questions are about sleeping. Tell me what you are thinking when I
read the statement to you:
I am satisfied with the amount I sleep at night.
Please repeat this statement in your own words.
Would this be easy or hard to answer?
What does “satisfied” mean to you?
How many hours do you sleep?
Would you be able to remember how many times you were satisfied with the
amount of time you slept in the past 2 weeks?
The TPN pump disrupts my sleep.
Please repeat this statement in your own words.
Would this be easy or hard to answer?
What does “disrupts” mean to you?
In what way does your TPN pump disrupt your sleep?
Would you be able to remember how many times the pump disrupted your
sleep in the past 2 weeks?
My sleep is disrupted because I have to get up to move my bowels or change my
ostomy appliance.
Please repeat this statement in your own words,
Would this be easy or hard to answer?
What does “disrupted” mean to you?
Would you be able to remember how many times your sleep was disrupted
because of needing to move your bowels or empty your ostomy
appliance
in the past 2 weeks?
My sleep is disrupted because I have to get up to urinate.
Please repeat this statement in your own words.
Would this be easy or hard to answer?
What does “urinate” mean to you?
What does “disrupted sleep” mean to you?
Would you be able to remember how many times your sleep was disrupted to
get up and urinate in the past 2 weeks?

Before I ask you the next question, please tell me if you have an ostomy or if you
go to the bathroom to move your bowels on the toilet?
If YES,
I move my bowels many times during the day.
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Please repeat this statement in your own words.
Would this be easy or hard to answer?
What does “move my bowels” mean to you?
What does “many times a day” mean to you?
Would you be able to remember how many days you had to move your bowels
many times a day in the past 2 weeks?
I move my bowels many times during the night.
Please repeat this statement in your own words.
Would this be easy or hard to answer?
What does “many times during the night” mean to you?
Would you be able to remember how many nights you had to move your
bowels throughout the night in the past 2 weeks?
I have to move my bowels urgently.
Please repeat this statement in your own words.
Would this be easy or hard to answer?
What does “urgently” mean to you?
Would you be able to remember how many days you had to move your bowels
urgently in the past 2 weeks?
I have episodes of uncontrollable diarrhea.
Please repeat this statement in your own words.
Would this be easy or hard to answer?
What does “uncontrollable diarrhea” mean to you?
Would you be able to remember how many episodes of uncontrollable diarrhea
you had in the past 2 weeks?
I have to move my bowels as soon as I eat food.
Please repeat this statement in your own words.
Would this be easy or hard to answer?
What does “as soon as you eat” mean to you?
Would you be able to remember how times you had to move your bowels as
soon as you ate in the past 2 weeks?
I plan my daily activities around how much diarrhea I have.
Please repeat this statement in your own words.
Would this be easy or hard to answer?
What does “daily activities” mean to you?
What does it mean to “plan around” your daily activities?
Would you be able to remember how many days you to had plan your daily
activities around how much diarrhea you have?
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If NO,
I empty my ostomy appliance many times during the day.
Please repeat this statement in your own words.
Would this be easy or hard to answer?
What does “many times” mean to you?
What does “empty my ostomy appliance” mean to you?
Would you be able to remember how many days you have to empty you
ostomy appliance many times a day in the past 2 weeks?
I empty my ostomy appliance many times during the night.
Please repeat this statement in your own words.
Would this be easy or hard to answer?
What does “many times during the night” mean to you?
Would you be able to remember how many nights you had to empty your
ostomy appliance many times in the past 2 weeks?
I have to empty my ostomy appliance urgently.
Please repeat this statement in your own words.
Would this be easy or hard to answer?
What does “urgently” mean to you?
Would you be able to remember how many times you had to urgently empty
your ostomy appliance in the past 2 weeks?
I have episodes of uncontrollable ostomy leakage
Please repeat this statement in your own words.
Would this be easy or hard to answer?
What does “uncontrollable leakage” mean to you?
Would you be able to remember how many days you had uncontrollable
ostomy leakage in the past 2 weeks?
I have to empty my ostomy appliance as soon as I eat food.
Please repeat this statement in your own words.
Would this be easy or hard to answer?
What does “as soon as you eat” mean to you?
Would you be able to remember how many times you had to empty your
ostomy appliance as soon as you ate food in the past 2 weeks?
I plan my daily activities around how much ostomy output I have.
Please repeat this statement in your own words.
Would this be easy or hard to answer?
What does “daily activities” mean to you?
What does “ostomy output” mean to you?
Would you be able to remember how many days you had to plan your daily
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activities around how much ostomy output you have move in the past 2 weeks?

True/False
Good quality of life means being able to do what I want to do when I want to do it.
Please repeat this statement in your own words.
Would this be easy or hard to answer?
Having one or more nights without TPN is important to me.
Please repeat this statement in your own words.
Would this be easy or hard to answer?
Having a shorter TPN infusion schedule is important to me.
Please repeat this statement in your own words.
Would this be easy or hard to answer?
I feel relieved knowing my nutritional needs are being met by TPN.
Please repeat this statement in your own words.
Would this be easy or hard to answer?
What does the term “nutritional needs” mean to you?
What does it mean to “have your nutritional needs met”?
I do not need to eat because I receive TPN.
Please repeat this statement in your own words.
Would this be easy or hard to answer?
What does “do not need to eat” mean to you?
I am fearful of developing complications related to my catheter.
Please repeat this statement in your own words.
Would this be easy or hard to answer?
What does “complications related to my catheter” mean to you?
What does “fearful” mean to you?
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I understand the need for being on TPN.
Please repeat this statement in your own words.
Would this be easy or hard to answer?
What does “need for being on TPN” mean to you?

I am informed and well trained about managing my TPN.
Please repeat this statement in your own words.
Would this be easy or hard to answer
What does “informed” mean to you?
What does “well-trained” mean to you?
What does “managing my TPN” mean to you?

I am informed and well trained about the care of my catheter.
Please repeat this statement in your own words.
Would this be easy or hard to answer?
In this instance, what does “informed” mean to you?
What does “well-trained” mean to you?
I am informed and well trained about using my pump.
Please repeat this statement in your own words.
Would this be easy or hard to answer?
In this instance, what does “informed” mean to you?
What does “well-trained to take care of my catheter” mean to you?
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I am informed and well trained about signs and symptoms of infection.
Please repeat this statement in your own words.
Would this be easy or hard to answer?
What does “signs and symptoms of infection” mean to you?
In this instance, what does “informed” mean to you?
What does “using my pump” mean to you?
I am informed and well trained about signs and symptoms of dehydration.
Please repeat this statement in your own words.
Would this be easy or hard to answer?
What does “signs and symptoms of dehydration” mean to you?
In this instance, what does “informed” mean to you?
What does “well-trained” mean to you?
I understand my diet and what I should be eating.
Please repeat this statement in your own words.
Would this be easy or hard to answer?
What does “diet” mean to you?
What does “should be eating” mean to you?
What does it mean to “understand”?
I know whom to call when I have questions about my TPN.
Please repeat this statement in your own words.
Would this be easy or hard to answer?
Who do you call when you have questions about your TPN?
Would you call that person if you had questions about your TPN?
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What does it mean to have “questions about my TPN”?
I feel well supported by my home care specialists.
Please repeat this statement in your own words.
Would this be easy or hard to answer?
What does “home care specialists” mean to you?
Do you have a “home care specialist?”
What does the concept of feeling well supported mean to you?
I received information about local or national support groups for TPN.
Please repeat this statement in your own words.
Would this be easy or hard to answer?
Appendix G: Oral Consent Script and Interview Guide

What does “support group” mean to you?
Do you utilize local or national support groups?
If yes, which support group do you utilize?

I wish I knew more about my TPN.
Please repeat this statement in your own words.
Would this be easy or hard to answer?
What does “know more” mean to you?
Do you know how to learn more about your TPN?

Now, a few more questions are about you:
What is your age in years?
Are you male or female?
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What is your highest level of education?
How many people live in your household?
Are you married, single, or divorced?
Do you have a caregiver to help with TPN procedures, and if yes, who?
What is your race?
What is your ethnicity?

Finally, I would like to get your personal impression on the HPN-PROQ. Do you think
this may be useful during a visit the doctor, clinician, or other health-care professional
who helps you manage your TPN?
Thank you for participating in this study. If is okay with you, may I contact you at a
future date to clarify some of the feedback you provided me with today?
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HPN-PROQ
Thank you for agreeing to participate in this study. Research by Winkler et al. (2010)
determined that patients in the Home Parenteral Nutrition (HPN) population perceived their
routine medical appointments as a parenteral nutrition “tune-up,” with sessions focusing
primarily on disease aspects of care. In addition to medical examination and nutrition
assessment, HPN patients desired a more holistic approach to parenteral nutrition management
incorporating both physical and emotional support.

Patient reported outcomes comprise information from patients about health
conditions and management, making them a valuable tool to identify concerns and in
facilitating communication around patients’ health-related quality of life. The Home
Parenteral Nutrition Patient Reported Outcome Questionnaire (HPN-PROQ) is meant to be
completed by adult home parenteral nutrition patients.

This is a University of Rhode Island research study; the principal investigator is Dr.
Geoffrey Greene. The completion of this worksheet represents your informed consent and
agreement to participate in this study. Your responses will remain confidential and results
will not be published in a way that may identify you.

Attached to this cover letter is the Content Validity Index Worksheet. Instructions are
included within the document. At your earliest convenience, please complete the worksheet,
save as a PDF, and return it to HPNpatientoutcomes@etal.uri.edu by 2/10/17. If you have
any questions, please contact me via email.
-This research is being conducted in collaboration with Marion Winkler, PhD, RD, LDN,
CNSC-
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HPN-PROQ
of Science-Nutrition and Dietetics
University of Rhode Island

Expert Review: Content Validity Index
Directions: Attached is the HPN-PROQ. Please rate each item on the Home
Parenteral Nutrition Patient Reported Outcome Questionnaire (HPN-PRO-Q) based
on its relevance to the HPN population. ** Please CHECK THE BOX next to the
number that corresponds to your answer.
1="Not Relevant", 2="Somewhat Relevant", 3="Quite Relevant", or 4="Highly
Relevant".

SEE EXAMPLES 1 & 2 EXPERT REVIEWERS: Please CHECK THE
BOX next to the number that corresponds to your answer. PLEASE MAKE SURE
YOU ONLY CHOOSE ONE BOX PER QUESTION.
During the past 2 weeks, please estimate how often you have experienced
any of the following situations.
1.

I felt like my health limited the things I want to do in my life.
Not at all -----------------------------------|--------------------------------- Every day

Not Relevant
1
2.

Somewhat Relevant
2

Quite Relevant
3

Highly Relevant
4

Being on TPN was difficult to cope with emotionally.

Not at all --------------------------------------|--------------------------------- Every
day
Not Relevant
Somewhat Relevant
Quite Relevant
Highly Relevant
1
2
3
4
- Please continue to the next page -

\
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Home Parenteral Nutrition Patient Reported Outcomes Questionnaire
CVI WORKSHEET

Patient Instructions:
This questionnaire is intended to help you identify areas of concern or problems with
your home TPN over the last 2 weeks that may affect your quality of life and/or your
ability to do the things you would like to do. These patient-reported outcomes (PRO)
may be used to prioritize what you would like to discuss with your physician, health
care professional, or members of your home parenteral nutrition management team as
well as set goals for your care.
Healthcare Professional Instructions: The responses on this questionnaire are
intended to facilitate discussion between patient and practitioner regarding patient
goals related to home TPN and lifestyle adaptation.
“TPN” = total parenteral nutrition solution/formula.
“TPN therapy” = procedures/equipment/devices necessary to administer the TPN
solution/formula
HPN Consumers: Please place a “X” on the dotted line where it most clearly
indicates the frequency of occurrence for each of the given situations over the
past two weeks.
EXPERT REVIEWERS: Please CHECK THE BOX next to the number that
corresponds to your answer. PLEASE MAKE SURE YOU ONLY CHOOSE ONE
BOX PER QUESTION.
During the past 2 weeks, please estimate how often you experienced any of the
following situations.
1.

I felt like my health limited the things I want to do in my life.
Not at all -----------------------------------|--------------------------------- Every day

Not Relevant
1
2.

Somewhat Relevant
2

Quite Relevant
3

Highly Relevant
4

Being on TPN was difficult to cope with emotionally.
Not at all -----------------------------------|--------------------------------- Every day

Not Relevant
1

Somewhat Relevant
2

Quite Relevant
3

- Please continue to the next page -
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Highly Relevant
4

During the past 2 weeks, please estimate how often you experienced any of the
following situations.
3.

My daily activities were limited by my TPN infusion schedule.
Not at all -----------------------------------|--------------------------------- Every day

Not Relevant
1
4.

Somewhat
Relevant
2

Quite Relevant
3

Highly Relevant
4

Carrying my TPN solution limited what I could do.
Not at all -----------------------------------|--------------------------------- Every day

Not Relevant
1
5.

Somewhat
Relevant
2

Quite Relevant
3

Highly Relevant
4

I felt physically strong.
Not at all -----------------------------------|--------------------------------- Every day

Not Relevant
1
6.

Somewhat
Relevant
2

Quite Relevant
3

Highly Relevant
4

I was able to participate in the activities I enjoy.
Not at all -----------------------------------|--------------------------------- Every day

Not Relevant
1
7.

Somewhat
Relevant
2

Quite Relevant
3

Highly Relevant
4

I was able to walk without difficulty.
Not at all -----------------------------------|--------------------------------- Every day

Not Relevant
1

Somewhat
Relevant
2

Quite Relevant
3

- Please continue to the next page -
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Highly Relevant
4

During the past 2 weeks, please estimate how often you experienced any of the
following situations.
8.

I was able to climb up and down stairs without difficulty.
Not at all -----------------------------------|--------------------------------- Every day

Not Relevant
1
9.

Somewhat
Relevant
2

Quite Relevant
3

Highly Relevant
4

I was able to rise from a chair or bed without difficulty.
Not at all -----------------------------------|--------------------------------- Every day

Not Relevant
1

Somewhat
Relevant
2

Quite Relevant
3

Highly Relevant
4

10. I was able to pick up an object from the floor without difficulty.
Not at all -----------------------------------|--------------------------------- Every day
Not Relevant
1

Somewhat
Relevant
2

Quite Relevant
3

Highly Relevant
4

11. I needed to nap when I felt tired.
Not at all -----------------------------------|--------------------------------- Every day
Not Relevant
1

Somewhat
Relevant
2

Quite Relevant
3

Highly Relevant
4

12. I had enough strength and stamina to do daily chores or work.
Not at all -----------------------------------|--------------------------------- Every day
Not Relevant
1

Somewhat
Relevant
2

Quite Relevant
3

- Please continue to the next page -
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Highly Relevant
4

During the past 2 weeks, please estimate how often you experienced any of the
following situations.
13. The TPN pump disrupted my sleep.
Not at all -----------------------------------|--------------------------------- Every day
Somewhat
Quite Relevant
Highly Relevant
Relevant
3
4
2
My sleep was disrupted because I had to get up to move my bowels or empty my
14.
ostomy bag.
Not Relevant
1

Not at all -----------------------------------|--------------------------------- Every day
Not Relevant
1

Somewhat
Relevant
2

Quite Relevant
3

Highly Relevant
4

15. My sleep was disrupted because I had to get up to urinate.
Not at all -----------------------------------|--------------------------------- Every day
Not Relevant
1

Somewhat
Relevant
2

Quite Relevant
3

Highly Relevant
4

16. I ate comfortably in social situations and around others.
Not at all -----------------------------------|--------------------------------- Every day
Not Relevant
1

Somewhat
Relevant
2

Quite Relevant
3

Highly Relevant
4

17. Eating caused me to have gas or feel bloated.
Not at all -----------------------------------|--------------------------------- Every day
Not Relevant
1

Somewhat
Relevant
2

Quite Relevant
3

- Please continue to the next page -
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Highly Relevant
4

During the past 2 weeks, please estimate how often you experienced any of the
following situations.
18. Eating caused me to have pain.
Not at all -----------------------------------|--------------------------------- Every day
Not Relevant
1

Somewhat
Relevant
2

Quite Relevant
3

Highly Relevant
4

***Answer questions 19-21 if you do NOT have an end-jejunostomy or ileostomy
but do have bowel in continuity. ***
During the past 2 weeks, please estimate how often you experienced any of the
following situations.
19. I had episodes of uncontrollable diarrhea.
Not at all -----------------------------------|--------------------------------- Every day
Not Relevant
1

Somewhat Relevant
2

Quite Relevant
3

Highly Relevant
4

20. I had to move my bowels shortly after I ate food.
Not at all -----------------------------------|--------------------------------- Every day
Not Relevant
1

Somewhat Relevant
2

Quite Relevant
3

Highly Relevant
4

21. I had to rearrange my daily plans because of how much diarrhea I had.
Not at all -----------------------------------|--------------------------------- Every day
Not Relevant
1

Somewhat Relevant
2

Quite Relevant
3

Highly Relevant
4

***Answer questions 22-24 if you HAVE an end-jejunostomy or ileostomy. ***
During the past 2 weeks, please estimate how often you experienced any of the
following situations.
22. I had episodes of uncontrollable ostomy leakage.
Not at all -----------------------------------|--------------------------------- Every day
Not Relevant
1

Somewhat Relevant
2

Quite Relevant
3
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Highly Relevant
4

During the past 2 weeks, please estimate how often you experienced any of the
following situations.
23. I had to empty my ostomy bag shortly after I ate food.
Not at all -----------------------------------|--------------------------------- Every day
Not Relevant
1

Somewhat Relevant
2

Quite Relevant
3

Highly Relevant
4

24. I had to rearrange my daily plans because of how much ostomy output I had.
Not at all -----------------------------------|--------------------------------- Every day
Not Relevant
1

Somewhat Relevant
2

Quite Relevant
3

Highly Relevant
4

- Please continue to the next page for True/False section-
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How TRUE or FALSE are the following statements to you?
1.

Good quality of life means being able to do what I want to do when I want to do
it.
Definitely false ----------------------------|------------------------------- Definitely true

Not Relevant
1
2.

Somewhat Relevant
2

Quite Relevant
3

Highly Relevant
4

I eat and enjoy the foods I want to eat.
Definitely false ----------------------------|------------------------------- Definitely true

Not Relevant
1
3.

Somewhat Relevant
2

Quite Relevant
3

Highly Relevant
4

I am confident in my ability to perform TPN procedures on my own.
Definitely false ----------------------------|------------------------------- Definitely true
Not Relevant
1

4.

Somewhat Relevant
2

Quite Relevant
3

Highly Relevant
4

Having one or more nights or days without TPN is important to me.
Definitely false ----------------------------|------------------------------- Definitely true

Not Relevant
1
5.

Somewhat Relevant
2

Quite Relevant
3

Highly Relevant
4

Having a shorter TPN infusion schedule is important to me.
Definitely false ----------------------------|------------------------------- Definitely true

Not Relevant
1
6.

Somewhat Relevant
2

Quite Relevant
3

Highly Relevant
4

I feel relieved knowing my nutritional needs are being met by TPN therapy.
Definitely false ----------------------------|------------------------------- Definitely true

Not Relevant
1

Somewhat Relevant
2

Quite Relevant
3

- Please continue to the next page -
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Highly Relevant
4

How TRUE or FALSE are the following statements to you?
7.

I am fearful of developing complications related to my TPN therapy and/or
central line.
Definitely false ----------------------------|------------------------------- Definitely true

Not Relevant
1
8.

Somewhat Relevant
2

Quite Relevant
3

Highly Relevant
4

I understand my need for being on TPN therapy.
Definitely false ----------------------------|------------------------------- Definitely true

Not Relevant
1
9.

Somewhat Relevant
2

Quite Relevant
3

Highly Relevant
4

I know and have been trained on how to manage my TPN therapy.
Definitely false ----------------------------|------------------------------- Definitely true

Not Relevant
1
10.

Somewhat Relevant
2

Quite Relevant
3

Highly Relevant
4

I know and have been trained on how to care for my central line.
Definitely false ----------------------------|------------------------------- Definitely true

Not Relevant
1
11.

Somewhat Relevant
2

Quite Relevant
3

Highly Relevant
4

I know and have been trained on how to use my pump.
Definitely false ----------------------------|------------------------------- Definitely true

Not Relevant
1
12.

Somewhat Relevant
2

Quite Relevant
3

Highly Relevant
4

I know and have been trained on the signs and symptoms of a central line
infection.
Definitely false ----------------------------|------------------------------- Definitely true

Not Relevant
1

Somewhat Relevant
2

Quite Relevant
3

- Please continue to the next page -
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Highly Relevant
4

How TRUE or FALSE are the following statements to you?
13.

I know and have been trained on the signs and symptoms of dehydration.
Definitely false ----------------------------|------------------------------- Definitely true

Not Relevant
1
14.

Somewhat Relevant
2

Quite Relevant
3

Highly Relevant
4

I know and have been trained about my diet and what I should be eating.
Definitely false ----------------------------|------------------------------- Definitely true

Not Relevant
1
15.

Somewhat Relevant
2

Quite Relevant
3

Highly Relevant
4

I know whom to call when I have questions about my TPN therapy.
Definitely false ----------------------------|------------------------------- Definitely true

Not Relevant
1
16.

Somewhat Relevant
2

Quite Relevant
3

Highly Relevant
4

I feel emotionally supported by my family and friends.
Definitely false ----------------------------|------------------------------- Definitely true

Not Relevant
1
17.

Somewhat Relevant
2

Quite Relevant
3

Highly Relevant
4

I feel well supported by my home care specialists.
Definitely false ----------------------------|------------------------------- Definitely true

Not Relevant
1
18.

Somewhat Relevant
2

Quite Relevant
3

Highly Relevant
4

I received information about local or national support groups for TPN therapy.

Definitely false ----------------------------|------------------------------- Definitely
true
Not Relevant
Somewhat Relevant
Quite Relevant
Highly Relevant
1
2
3
4
- Please continue to the next page -
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How TRUE or FALSE are the following statements to you?
19.

I wish I knew more about my TPN therapy.

Definitely false ----------------------------|------------------------------- Definitely
true
Not Relevant
Somewhat Relevant
Quite Relevant
Highly Relevant
1
2
3
4

Thank you for completing the
Home Parenteral Nutrition Patient Reported Outcomes Questionnaire
Content Validity Index Worksheet
Please SAVE AS a PDF and email to HPNpatientoutcomes@etal.uri.edu
CONTENT VALIDATION OF A HOME PARENTERAL NUTRITION PATIENT
REPORTED OUTCOMES QUESTIONNAIRE
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Appendix F: Phase I Themes and Representative Quotations
Concerns with tone
Item Tested

Representative Quotations

CRT Decision

Implication/Interpretation

Eliminate Item

Address concerns with
the overall tone of the
item and the patient’s
most salient concern.

"I think normal is hard to define
for everybody.
“Normal is relative”
“I am able to live what I
consider a normal lifestyle.”
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“I think this question is too
generalized. each of us has his
own normal.”
“I don’t like the word normal
because there’s nothing normal
with someone on TPN”.
"When I say medical condition,
I don’t think it’s just referring to
TPN. Mostly (because) I still I
have other issues."

“I feel like my medical
condition controls my life”

“We all have things that come
up, but I think we are a little
more hypersensitive”
“…dictates your day to day (not
controls)".

Revise Item
“I felt like my health
limited the things I want
to do in my life.”

Increased acceptability of
the item, tailored to
patient feedback

“My TPN schedule limits my
freedom to participate in daily
activities”.

“…to limit my freedom to me
makes me think like you can’t. I
think it’s a more strict of a
term".
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“these are two entirely different
schedules that you have to focus
on because TPN schedule might
be being home making the
deliveries, getting tools, so that
schedule is completely different
than how many hours you’re
infusing.
Issues with ambiguity and meaning

“Being on TPN is difficult to
cope with”.

“…it’s a lot more difficult than
to cope…I think if you put
emotionally there would
describe it more specifically.”

Revise Item
“My daily activities
were limited by my TPN
infusion schedule.” Add
“infusion” to all items
referring to TPN
schedule.

Revise Item
“Being on TPN was
difficult to cope with
emotionally”.

“What do you mean, urgently?”
“I have to empty my ostomy
appliance urgently”

“…do you mean within five
minutes...or longer?”

Eliminate Item

Increased acceptability of
the item, increased
clarity, tailored to patient
feedback

Increased acceptability of
the item, increased
clarity, tailored to patient
feedback

Addressed unnecessary
confusion related to
intended purpose of the
item, purpose covered in
other items

“I move my bowels many
times during the day” and “I
empty my ostomy appliance
many times during the
day/night”

“I am satisfied with the
amount I sleep at night”

“I would wonder about what
you mean with “many”? Many
to me I don’t think as my
frequency as many but my
friend with normal bowels they
would say like “what... you go
many times”.
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“I think it would be difficult to
answer just because the fact the
it varies so much that, someone
can be satisfied with no sleep so
it’s very individual”

“That’s ambiguous to me... I am
able to take care of my hygiene,
“I am able to take care of
in that sense I am able to take
myself”.
care of myself. I can brush my
teeth…but I can’t live on my
own.
Concerns with use of jargon or word choice
“My sleep is disrupted because
I have to get up to move my
bowels or change my ostomy
appliance.”

“Change is not appropriate in
here... you don’t change it, you
empty the bag.”

“I am fearful of developing
complications related to my

“Central line would cover
everything.” “…most of the

Eliminate Item

Addressed unnecessary
confusion related to
intended purpose of the
item, intent covered in
other items.

Eliminate Item

Addressed unnecessary
confusion related to
intended purpose of the
item, purpose covered in
other items

Eliminate Item

Addressed unnecessary
confusion related to
intended purpose of the
item, purpose covered in
other items

Revise Item
“My sleep was disrupted
because I had to get up
to move my bowels or
empty my ostomy bag”
Revise Item
“I am fearful of

Increased acceptability of
the item.
Increased acceptability of
the item.

catheter” and “I am informed
and well trained about how to
care for my catheter”

people say central line and I
don’t know if everyone knows
about a catheter”
“if you changed catheter to
central line would be clear”

developing
complications related to
my central line” and “I
am informed and well
trained about how to
care for my central
line”
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“The question here for me is the
well-trained part…obviously,
my situation is different but it
wouldn’t be specifically trained
doing that, so that’s where I’m
informed but not trained”
“I am informed and welltrained to…”

“Well-trained doesn’t seem like
something I would use, maybe
knowledgeable?”
“Informed would be I
understand why I have TPN, I
know what it is, what it’s doing
for me, and I have been taught
or trained how to manage.”

Revise Item
I understand and have
been trained to….”

Eliminated unnecessary
confusion related to
intended purpose of the
item.

